{"entity":"merck","name":"Merck & Co.","kind":"money","summary":"Merck & Co.'s timeline holds 494 money & deals claims from 2006 to 2026. The latest took effect on October 31, 2026.","counts":{"total":508,"by_kind":{"people":3,"money":494,"products":0,"models":0,"other":11}},"events":[{"date":"2006-12-31","until":"2007-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,914,700,000 United States dollar\", as of 2006-12-31 (until 2007-12-31). Claim clm_1F1D245F44D6, https://asof.is/claim/clm_1F1D245F44D6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_1F1D245F44D6","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"5,914,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1F1D245F44D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"date":"2006-12-31","until":"2007-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 19,965,800,000 United States dollar\", as of 2006-12-31 (until 2007-12-31). Claim clm_4496266C128D, https://asof.is/claim/clm_4496266C128D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_4496266C128D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"19,965,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4496266C128D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2009, filed 2010-03-01"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 20,591,400,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_5165C273DFBC, https://asof.is/claim/clm_5165C273DFBC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_5165C273DFBC","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"20,591,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5165C273DFBC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2009, filed 2010-03-01"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 24,197,700,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_5DBE0DD30DAD, https://asof.is/claim/clm_5DBE0DD30DAD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_5DBE0DD30DAD","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"24,197,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5DBE0DD30DAD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-03-01"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 4,882,800,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_E830E102F96E, https://asof.is/claim/clm_E830E102F96E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_E830E102F96E","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"4,882,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E830E102F96E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-03-01"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 3,275,400,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_EF9A8E802FB5, https://asof.is/claim/clm_EF9A8E802FB5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_EF9A8E802FB5","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,275,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EF9A8E802FB5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-03-01"}},{"date":"2007-12-31","until":"2008-06-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,336,100,000 United States dollar\", as of 2007-12-31 (until 2008-06-30). Claim clm_F2BA78F20E9F, https://asof.is/claim/clm_F2BA78F20E9F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_F2BA78F20E9F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"5,336,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F2BA78F20E9F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 462,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_10D2DE05595D, https://asof.is/claim/clm_10D2DE05595D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_10D2DE05595D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"462,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_10D2DE05595D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 2,705,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_39FFF425906C, https://asof.is/claim/clm_39FFF425906C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_39FFF425906C","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,705,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39FFF425906C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 4,921,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_66C40BC5AB58, https://asof.is/claim/clm_66C40BC5AB58, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_66C40BC5AB58","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,921,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_66C40BC5AB58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 906,000,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_A11256338AE1, https://asof.is/claim/clm_A11256338AE1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_A11256338AE1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"906,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A11256338AE1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 893,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_0012D0EF4581, https://asof.is/claim/clm_0012D0EF4581, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_0012D0EF4581","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"893,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0012D0EF4581","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 4,576,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_2C246AABD63D, https://asof.is/claim/clm_2C246AABD63D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_2C246AABD63D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,576,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2C246AABD63D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2008-09-30","until":"2008-12-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 3,159,000,000 United States dollar\", as of 2008-09-30 (until 2008-12-31). Claim clm_B27C1DE2C9B9, https://asof.is/claim/clm_B27C1DE2C9B9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_B27C1DE2C9B9","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,159,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B27C1DE2C9B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 614,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_BEEB13A3FCFF, https://asof.is/claim/clm_BEEB13A3FCFF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_BEEB13A3FCFF","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"614,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BEEB13A3FCFF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2008-12-31","until":"2009-06-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 18,758,300,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_0C23DECD923D, https://asof.is/claim/clm_0C23DECD923D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_0C23DECD923D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"18,758,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0C23DECD923D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-03-01"}},{"date":"2008-12-31","until":"2009-03-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 4,368,300,000 United States dollar\", as of 2008-12-31 (until 2009-03-31). Claim clm_5C437D324996, https://asof.is/claim/clm_5C437D324996, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_5C437D324996","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,368,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C437D324996","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"date":"2008-12-31","until":"2009-06-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 47,195,700,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_5FD9363AA3ED, https://asof.is/claim/clm_5FD9363AA3ED, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_5FD9363AA3ED","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"47,195,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5FD9363AA3ED","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-03-01"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 23,850,300,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_6AB36311B283, https://asof.is/claim/clm_6AB36311B283, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_6AB36311B283","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"23,850,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6AB36311B283","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-03-01"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 7,808,400,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_AC1DCB2822D2, https://asof.is/claim/clm_AC1DCB2822D2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_AC1DCB2822D2","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"7,808,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AC1DCB2822D2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-03-01"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 4,805,300,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_AD7D2ACA144B, https://asof.is/claim/clm_AD7D2ACA144B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_AD7D2ACA144B","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"4,805,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AD7D2ACA144B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-03-01"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,017,100,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_4EDF0B1989AE, https://asof.is/claim/clm_4EDF0B1989AE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_4EDF0B1989AE","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,017,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4EDF0B1989AE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,425,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_AA38C432CDB7, https://asof.is/claim/clm_AA38C432CDB7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_AA38C432CDB7","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,425,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AA38C432CDB7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 5,385,200,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_C8A4E67B495C, https://asof.is/claim/clm_C8A4E67B495C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_C8A4E67B495C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"5,385,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C8A4E67B495C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,224,200,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_E816BE82558E, https://asof.is/claim/clm_E816BE82558E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_E816BE82558E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,224,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E816BE82558E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 671,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_048EC2C80B3F, https://asof.is/claim/clm_048EC2C80B3F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_048EC2C80B3F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"671,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_048EC2C80B3F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 12,035,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_133163071D45, https://asof.is/claim/clm_133163071D45, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_133163071D45","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"12,035,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_133163071D45","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 2,989,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_2285A0A34C73, https://asof.is/claim/clm_2285A0A34C73, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_2285A0A34C73","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,989,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2285A0A34C73","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 29,545,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_3184EF4E173F, https://asof.is/claim/clm_3184EF4E173F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_3184EF4E173F","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"29,545,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3184EF4E173F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2009-06-30","until":"2009-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 5,899,900,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_3CA7D1DAEFB3, https://asof.is/claim/clm_3CA7D1DAEFB3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_3CA7D1DAEFB3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"5,899,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3CA7D1DAEFB3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2010, filed 2010-08-06"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 0 shares\", as of 2009-06-30 (until 2009-09-30). Claim clm_6D871C86295C, https://asof.is/claim/clm_6D871C86295C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_6D871C86295C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"0 shares","status":"superseded","assertable":true,"id":"clm_6D871C86295C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 863,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_C47CB8AEE9D1, https://asof.is/claim/clm_C47CB8AEE9D1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309025362/0000950123-09-025362-index.htm.","url":"https://asof.is/claim/clm_C47CB8AEE9D1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"863,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C47CB8AEE9D1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2009, filed 2009-07-24"}},{"date":"2009-09-30","until":"2010-03-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 6,049,700,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_0FE78409134C, https://asof.is/claim/clm_0FE78409134C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_0FE78409134C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"6,049,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0FE78409134C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2010, filed 2010-11-08"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 12,900,000,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_43B087FEC347, https://asof.is/claim/clm_43B087FEC347, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_43B087FEC347","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"12,900,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_43B087FEC347","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 4,312,000,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_4D5FB6156251, https://asof.is/claim/clm_4D5FB6156251, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_4D5FB6156251","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,312,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4D5FB6156251","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2009-09-30","until":"2010-01-29","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 1,639,151,392 shares\", as of 2009-09-30 (until 2010-01-29). Claim clm_5904E31120BB, https://asof.is/claim/clm_5904E31120BB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_5904E31120BB","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,639,151,392 shares","status":"superseded","assertable":true,"id":"clm_5904E31120BB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 30,547,000,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_5D1DFB0B7A44, https://asof.is/claim/clm_5D1DFB0B7A44, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_5D1DFB0B7A44","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"30,547,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5D1DFB0B7A44","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 913,000,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_9F8BAD62BE47, https://asof.is/claim/clm_9F8BAD62BE47, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_9F8BAD62BE47","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"913,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F8BAD62BE47","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 515,000,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_AAC4D7B22371, https://asof.is/claim/clm_AAC4D7B22371, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012309054872/0000950123-09-054872-index.htm.","url":"https://asof.is/claim/clm_AAC4D7B22371","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"515,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AAC4D7B22371","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-10-29"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 27,428,300,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_096391AC4DDE, https://asof.is/claim/clm_096391AC4DDE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_096391AC4DDE","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"27,428,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_096391AC4DDE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-03-01"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 5,845,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_2398410359B8, https://asof.is/claim/clm_2398410359B8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_2398410359B8","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"5,845,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2398410359B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-03-01"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,311,400,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_47722B45F6C8, https://asof.is/claim/clm_47722B45F6C8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_47722B45F6C8","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"9,311,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_47722B45F6C8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 12,901,300,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_7347BADF2C70, https://asof.is/claim/clm_7347BADF2C70, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_7347BADF2C70","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"12,901,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7347BADF2C70","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-03-01"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 59,058,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_ACC2D700771A, https://asof.is/claim/clm_ACC2D700771A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_ACC2D700771A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"59,058,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ACC2D700771A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-03-01"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 112,089,700,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_FEC4D5849978, https://asof.is/claim/clm_FEC4D5849978, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_FEC4D5849978","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"112,089,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FEC4D5849978","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-03-01"}},{"date":"2010-01-29","until":"2010-04-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,115,317,260 shares\", as of 2010-01-29 (until 2010-04-30). Claim clm_CFB9418D7005, https://asof.is/claim/clm_CFB9418D7005, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310018679/0000950123-10-018679-index.htm.","url":"https://asof.is/claim/clm_CFB9418D7005","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,115,317,260 shares","status":"superseded","assertable":true,"id":"clm_CFB9418D7005","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2009, filed 2010-03-01"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,026,700,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_49575E9AC377, https://asof.is/claim/clm_49575E9AC377, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_49575E9AC377","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,026,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49575E9AC377","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,236,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_6A4764C9BAB4, https://asof.is/claim/clm_6A4764C9BAB4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_6A4764C9BAB4","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,236,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6A4764C9BAB4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,422,200,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_A4F0D35F6BFE, https://asof.is/claim/clm_A4F0D35F6BFE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_A4F0D35F6BFE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"11,422,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A4F0D35F6BFE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 57,878,100,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_C4DA1A536A80, https://asof.is/claim/clm_C4DA1A536A80, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_C4DA1A536A80","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"57,878,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4DA1A536A80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 111,593,800,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_CEF5E014EF03, https://asof.is/claim/clm_CEF5E014EF03, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_CEF5E014EF03","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"111,593,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CEF5E014EF03","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 298,800,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_D1947D5F192E, https://asof.is/claim/clm_D1947D5F192E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_D1947D5F192E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"298,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D1947D5F192E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2010-04-30","until":"2010-07-30","published":"2010-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,118,252,244 shares\", as of 2010-04-30 (until 2010-07-30). Claim clm_6BFEF753A9AF, https://asof.is/claim/clm_6BFEF753A9AF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310045997/0000950123-10-045997-index.htm.","url":"https://asof.is/claim/clm_6BFEF753A9AF","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,118,252,244 shares","status":"superseded","assertable":true,"id":"clm_6BFEF753A9AF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2010, filed 2010-05-07"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,665,600,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_0BF16A111DB1, https://asof.is/claim/clm_0BF16A111DB1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_0BF16A111DB1","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,665,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0BF16A111DB1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2010, filed 2010-08-06"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,170,500,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_6F134AACBD0F, https://asof.is/claim/clm_6F134AACBD0F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_6F134AACBD0F","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,170,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F134AACBD0F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2010, filed 2010-08-06"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,150,900,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_8425BCAEBDE4, https://asof.is/claim/clm_8425BCAEBDE4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_8425BCAEBDE4","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,150,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8425BCAEBDE4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2010, filed 2010-08-06"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 752,400,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_87DCBE668D46, https://asof.is/claim/clm_87DCBE668D46, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_87DCBE668D46","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"752,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_87DCBE668D46","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2010, filed 2010-08-06"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,346,300,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_D746F14C7469, https://asof.is/claim/clm_D746F14C7469, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_D746F14C7469","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"11,346,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D746F14C7469","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2010, filed 2010-08-06"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,231,700,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_FB8799A4CF05, https://asof.is/claim/clm_FB8799A4CF05, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_FB8799A4CF05","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"55,231,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FB8799A4CF05","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2010, filed 2010-08-06"}},{"date":"2010-07-30","until":"2010-10-29","published":"2010-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,073,593,302 shares\", as of 2010-07-30 (until 2010-10-29). Claim clm_E46983415AD5, https://asof.is/claim/clm_E46983415AD5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310074336/0000950123-10-074336-index.htm.","url":"https://asof.is/claim/clm_E46983415AD5","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,073,593,302 shares","status":"superseded","assertable":true,"id":"clm_E46983415AD5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2010, filed 2010-08-06"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 341,600,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_12C2D8877AC1, https://asof.is/claim/clm_12C2D8877AC1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_12C2D8877AC1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"341,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_12C2D8877AC1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-08"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 107,840,100,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_8F41253963FE, https://asof.is/claim/clm_8F41253963FE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_8F41253963FE","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"107,840,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8F41253963FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2010, filed 2010-11-08"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,592,800,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_A0E18FFDE026, https://asof.is/claim/clm_A0E18FFDE026, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_A0E18FFDE026","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"55,592,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A0E18FFDE026","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2010, filed 2010-11-08"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,124,900,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_CAF2B5061F55, https://asof.is/claim/clm_CAF2B5061F55, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_CAF2B5061F55","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"11,124,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CAF2B5061F55","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2010, filed 2010-11-08"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,296,400,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_CB134DA21407, https://asof.is/claim/clm_CB134DA21407, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_CB134DA21407","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,296,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CB134DA21407","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2010, filed 2010-11-08"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,874,400,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_CED915E12E43, https://asof.is/claim/clm_CED915E12E43, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_CED915E12E43","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"9,874,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CED915E12E43","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2010, filed 2010-11-08"}},{"date":"2010-10-29","until":"2011-01-31","published":"2010-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,080,880,847 shares\", as of 2010-10-29 (until 2011-01-31). Claim clm_84A1426313AA, https://asof.is/claim/clm_84A1426313AA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012310102135/0000950123-10-102135-index.htm.","url":"https://asof.is/claim/clm_84A1426313AA","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,080,880,847 shares","status":"superseded","assertable":true,"id":"clm_84A1426313AA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2010, filed 2010-11-08"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 54,376,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_254D7953C206, https://asof.is/claim/clm_254D7953C206, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_254D7953C206","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"54,376,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_254D7953C206","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2010, filed 2011-02-28"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 10,900,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_2BED9DF30C40, https://asof.is/claim/clm_2BED9DF30C40, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_2BED9DF30C40","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"10,900,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2BED9DF30C40","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-28"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 861,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_39AC82F2B073, https://asof.is/claim/clm_39AC82F2B073, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_39AC82F2B073","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"861,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39AC82F2B073","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2010, filed 2011-02-28"}},{"date":"2010-12-31","until":"2016-12-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 45,987,000,000 United States dollar\", as of 2010-12-31 (until 2016-12-31). Claim clm_6B2D64844C16, https://asof.is/claim/clm_6B2D64844C16, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_6B2D64844C16","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"45,987,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6B2D64844C16","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2010, filed 2011-02-28"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,781,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_6FC7FC088DC8, https://asof.is/claim/clm_6FC7FC088DC8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_6FC7FC088DC8","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"105,781,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6FC7FC088DC8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2010, filed 2011-02-28"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 10,991,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_DAC5122F3F04, https://asof.is/claim/clm_DAC5122F3F04, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_DAC5122F3F04","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"10,991,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DAC5122F3F04","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2010, filed 2011-02-28"}},{"date":"2011-01-31","until":"2011-04-29","published":"2011-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,083,080,697 shares\", as of 2011-01-31 (until 2011-04-29). Claim clm_9BF1CD5FE3CA, https://asof.is/claim/clm_9BF1CD5FE3CA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311019286/0000950123-11-019286-index.htm.","url":"https://asof.is/claim/clm_9BF1CD5FE3CA","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,083,080,697 shares","status":"superseded","assertable":true,"id":"clm_9BF1CD5FE3CA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2010, filed 2011-02-28"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,695,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_138E9F8C2AD6, https://asof.is/claim/clm_138E9F8C2AD6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_138E9F8C2AD6","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"11,695,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_138E9F8C2AD6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2011, filed 2011-05-09"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,158,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_3319A0215022, https://asof.is/claim/clm_3319A0215022, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_3319A0215022","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,158,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3319A0215022","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2011, filed 2011-05-09"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,865,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_3B74FEDC21AF, https://asof.is/claim/clm_3B74FEDC21AF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_3B74FEDC21AF","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"105,865,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3B74FEDC21AF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2011, filed 2011-05-09"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,043,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_65A1060B45EF, https://asof.is/claim/clm_65A1060B45EF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_65A1060B45EF","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,043,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65A1060B45EF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-09"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 54,384,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_A3FD179A993F, https://asof.is/claim/clm_A3FD179A993F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_A3FD179A993F","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"54,384,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A3FD179A993F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2011, filed 2011-05-09"}},{"date":"2011-03-31","until":"2017-06-30","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,580,000,000 United States dollar\", as of 2011-03-31 (until 2017-06-30). Claim clm_DD04D89D847D, https://asof.is/claim/clm_DD04D89D847D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_DD04D89D847D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"11,580,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD04D89D847D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2011, filed 2011-05-09"}},{"date":"2011-04-29","until":"2011-07-29","published":"2011-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,086,584,896 shares\", as of 2011-04-29 (until 2011-07-29). Claim clm_6E96761DDE05, https://asof.is/claim/clm_6E96761DDE05, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.","url":"https://asof.is/claim/clm_6E96761DDE05","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,086,584,896 shares","status":"superseded","assertable":true,"id":"clm_6E96761DDE05","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2011, filed 2011-05-09"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,936,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_1C2CAA0EE3AB, https://asof.is/claim/clm_1C2CAA0EE3AB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_1C2CAA0EE3AB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,936,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1C2CAA0EE3AB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2011, filed 2011-08-08"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,496,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_33FE8193CAC6, https://asof.is/claim/clm_33FE8193CAC6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_33FE8193CAC6","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"55,496,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_33FE8193CAC6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2011, filed 2011-08-08"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,024,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_4193E1EB977C, https://asof.is/claim/clm_4193E1EB977C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_4193E1EB977C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"2,024,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4193E1EB977C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-08"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 12,342,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_7C24258D5116, https://asof.is/claim/clm_7C24258D5116, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_7C24258D5116","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"12,342,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7C24258D5116","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2011, filed 2011-08-08"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,195,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_FA9DB79A8B0C, https://asof.is/claim/clm_FA9DB79A8B0C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_FA9DB79A8B0C","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,195,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FA9DB79A8B0C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2011, filed 2011-08-08"}},{"date":"2011-07-29","until":"2011-10-31","published":"2011-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,080,796,992 shares\", as of 2011-07-29 (until 2011-10-31). Claim clm_BA6238CBFDB6, https://asof.is/claim/clm_BA6238CBFDB6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311074096/0000950123-11-074096-index.htm.","url":"https://asof.is/claim/clm_BA6238CBFDB6","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,080,796,992 shares","status":"superseded","assertable":true,"id":"clm_BA6238CBFDB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2011, filed 2011-08-08"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,954,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_1F7AAAEEBAA8, https://asof.is/claim/clm_1F7AAAEEBAA8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_1F7AAAEEBAA8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,954,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1F7AAAEEBAA8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,692,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_963AB2E89F87, https://asof.is/claim/clm_963AB2E89F87, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_963AB2E89F87","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,692,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_963AB2E89F87","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-09-30","until":"2011-12-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,534,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_D995E1344989, https://asof.is/claim/clm_D995E1344989, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_D995E1344989","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,534,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D995E1344989","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-09-30","until":"2011-12-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,140,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_E7890C41F190, https://asof.is/claim/clm_E7890C41F190, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_E7890C41F190","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"55,140,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E7890C41F190","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-09-30","until":"2011-12-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,253,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_F02B729073B0, https://asof.is/claim/clm_F02B729073B0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_F02B729073B0","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"14,253,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F02B729073B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-10-31","until":"2012-01-31","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,047,921,407 shares\", as of 2011-10-31 (until 2012-01-31). Claim clm_C5688CBF2599, https://asof.is/claim/clm_C5688CBF2599, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311096564/0000950123-11-096564-index.htm.","url":"https://asof.is/claim/clm_C5688CBF2599","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,047,921,407 shares","status":"superseded","assertable":true,"id":"clm_C5688CBF2599","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 54,517,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_1A15195A46D3, https://asof.is/claim/clm_1A15195A46D3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_1A15195A46D3","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"54,517,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A15195A46D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2011, filed 2012-02-28"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 13,531,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_253292471BFE, https://asof.is/claim/clm_253292471BFE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_253292471BFE","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"13,531,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_253292471BFE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-28"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,128,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_42F08F87AE73, https://asof.is/claim/clm_42F08F87AE73, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_42F08F87AE73","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"105,128,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_42F08F87AE73","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2011, filed 2012-02-28"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 8,467,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_6551D4B7258D, https://asof.is/claim/clm_6551D4B7258D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_6551D4B7258D","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"8,467,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6551D4B7258D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2011, filed 2012-02-28"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 6,272,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_7A9570A80387, https://asof.is/claim/clm_7A9570A80387, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_7A9570A80387","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"6,272,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A9570A80387","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2011, filed 2012-02-28"}},{"date":"2012-01-31","until":"2012-04-30","published":"2012-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,044,008,396 shares\", as of 2012-01-31 (until 2012-04-30). Claim clm_FC3671A94172, https://asof.is/claim/clm_FC3671A94172, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512084319/0001193125-12-084319-index.htm.","url":"https://asof.is/claim/clm_FC3671A94172","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,044,008,396 shares","status":"superseded","assertable":true,"id":"clm_FC3671A94172","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2011, filed 2012-02-28"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 54,860,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_1BEC26313598, https://asof.is/claim/clm_1BEC26313598, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_1BEC26313598","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"54,860,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1BEC26313598","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2012, filed 2012-05-08"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,656,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_5152EB930B57, https://asof.is/claim/clm_5152EB930B57, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_5152EB930B57","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"14,656,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5152EB930B57","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2012, filed 2012-05-08"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,862,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_95A2A8BB89F6, https://asof.is/claim/clm_95A2A8BB89F6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_95A2A8BB89F6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,862,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_95A2A8BB89F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2012, filed 2012-05-08"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,738,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_AD058299EEE7, https://asof.is/claim/clm_AD058299EEE7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_AD058299EEE7","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,738,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AD058299EEE7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2012, filed 2012-05-08"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,509,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_F0A7F5A9AE14, https://asof.is/claim/clm_F0A7F5A9AE14, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_F0A7F5A9AE14","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"105,509,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F0A7F5A9AE14","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2012, filed 2012-05-08"}},{"date":"2012-04-30","until":"2012-07-31","published":"2012-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,041,564,692 shares\", as of 2012-04-30 (until 2012-07-31). Claim clm_5053AEF3E520, https://asof.is/claim/clm_5053AEF3E520, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.","url":"https://asof.is/claim/clm_5053AEF3E520","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,041,564,692 shares","status":"superseded","assertable":true,"id":"clm_5053AEF3E520","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2012, filed 2012-05-08"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,793,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_13272BAF15D6, https://asof.is/claim/clm_13272BAF15D6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_13272BAF15D6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,793,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_13272BAF15D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,165,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_5897CB0342BB, https://asof.is/claim/clm_5897CB0342BB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_5897CB0342BB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,165,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5897CB0342BB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,194,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_6D6AE389AC7E, https://asof.is/claim/clm_6D6AE389AC7E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_6D6AE389AC7E","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"55,194,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6D6AE389AC7E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,525,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_7AC0686FEEC4, https://asof.is/claim/clm_7AC0686FEEC4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_7AC0686FEEC4","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"105,525,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7AC0686FEEC4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 16,752,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_7FF9FF3EAA65, https://asof.is/claim/clm_7FF9FF3EAA65, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_7FF9FF3EAA65","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"16,752,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7FF9FF3EAA65","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-07-31","until":"2012-10-31","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,045,632,274 shares\", as of 2012-07-31 (until 2012-10-31). Claim clm_79BF421588A8, https://asof.is/claim/clm_79BF421588A8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512341189/0001193125-12-341189-index.htm.","url":"https://asof.is/claim/clm_79BF421588A8","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,045,632,274 shares","status":"superseded","assertable":true,"id":"clm_79BF421588A8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,729,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_286B9F63C75F, https://asof.is/claim/clm_286B9F63C75F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_286B9F63C75F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,729,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_286B9F63C75F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-09-30","until":"2012-12-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 17,360,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_395E0D5CE587, https://asof.is/claim/clm_395E0D5CE587, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_395E0D5CE587","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"17,360,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_395E0D5CE587","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-09-30","until":"2012-12-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 55,747,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_70F74D2F16D3, https://asof.is/claim/clm_70F74D2F16D3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_70F74D2F16D3","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"55,747,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_70F74D2F16D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,918,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_C41FF0FA4FEA, https://asof.is/claim/clm_C41FF0FA4FEA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_C41FF0FA4FEA","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,918,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C41FF0FA4FEA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-09-30","until":"2012-12-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,301,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_CA202DF46EB3, https://asof.is/claim/clm_CA202DF46EB3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_CA202DF46EB3","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,301,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CA202DF46EB3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-10-31","until":"2013-01-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,040,071,937 shares\", as of 2012-10-31 (until 2013-01-31). Claim clm_850BEDD17E38, https://asof.is/claim/clm_850BEDD17E38, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512463586/0001193125-12-463586-index.htm.","url":"https://asof.is/claim/clm_850BEDD17E38","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,040,071,937 shares","status":"superseded","assertable":true,"id":"clm_850BEDD17E38","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 8,168,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_54A1A6CA4C2B, https://asof.is/claim/clm_54A1A6CA4C2B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_54A1A6CA4C2B","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"8,168,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_54A1A6CA4C2B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2012, filed 2013-02-28"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 13,451,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_61010F0E4CF3, https://asof.is/claim/clm_61010F0E4CF3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_61010F0E4CF3","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"13,451,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_61010F0E4CF3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-28"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 6,168,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_6A173E23DD15, https://asof.is/claim/clm_6A173E23DD15, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_6A173E23DD15","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"6,168,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6A173E23DD15","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2012, filed 2013-02-28"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,132,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_74DBDC2276F6, https://asof.is/claim/clm_74DBDC2276F6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_74DBDC2276F6","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,132,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_74DBDC2276F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-28"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 53,020,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_974390ADF164, https://asof.is/claim/clm_974390ADF164, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_974390ADF164","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"53,020,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_974390ADF164","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2012, filed 2013-02-28"}},{"date":"2013-01-31","until":"2013-04-30","published":"2013-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,022,367,538 shares\", as of 2013-01-31 (until 2013-04-30). Claim clm_8D39CFAFEB7C, https://asof.is/claim/clm_8D39CFAFEB7C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513084618/0001193125-13-084618-index.htm.","url":"https://asof.is/claim/clm_8D39CFAFEB7C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,022,367,538 shares","status":"superseded","assertable":true,"id":"clm_8D39CFAFEB7C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2012, filed 2013-02-28"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,593,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_283B3063FEFA, https://asof.is/claim/clm_283B3063FEFA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_283B3063FEFA","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,593,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_283B3063FEFA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2013, filed 2013-05-09"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 13,024,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_90FA1C2EE047, https://asof.is/claim/clm_90FA1C2EE047, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_90FA1C2EE047","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"13,024,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_90FA1C2EE047","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2013, filed 2013-05-09"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,907,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_911FFD783AD9, https://asof.is/claim/clm_911FFD783AD9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_911FFD783AD9","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,907,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_911FFD783AD9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2013, filed 2013-05-09"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 53,029,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_9DD1E2DA6948, https://asof.is/claim/clm_9DD1E2DA6948, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_9DD1E2DA6948","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"53,029,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9DD1E2DA6948","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2013, filed 2013-05-09"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,200,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_AB6793F263FE, https://asof.is/claim/clm_AB6793F263FE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_AB6793F263FE","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,200,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AB6793F263FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2013, filed 2013-05-09"}},{"date":"2013-04-30","until":"2013-07-31","published":"2013-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 3,019,611,844 shares\", as of 2013-04-30 (until 2013-07-31). Claim clm_11D540F5CFF2, https://asof.is/claim/clm_11D540F5CFF2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312513211374/0001193125-13-211374-index.htm.","url":"https://asof.is/claim/clm_11D540F5CFF2","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"3,019,611,844 shares","status":"superseded","assertable":true,"id":"clm_11D540F5CFF2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2013, filed 2013-05-09"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 15,090,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_494220063F74, https://asof.is/claim/clm_494220063F74, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_494220063F74","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"15,090,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_494220063F74","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2013, filed 2013-08-07"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,101,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_866963D28A7C, https://asof.is/claim/clm_866963D28A7C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_866963D28A7C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,101,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_866963D28A7C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2013, filed 2013-08-07"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 47,500,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_8979652BD6C4, https://asof.is/claim/clm_8979652BD6C4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_8979652BD6C4","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"47,500,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8979652BD6C4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2013, filed 2013-08-07"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 906,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_9DA08D3D51BF, https://asof.is/claim/clm_9DA08D3D51BF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_9DA08D3D51BF","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"906,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9DA08D3D51BF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2013, filed 2013-08-07"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,876,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_DCC0FF436A6C, https://asof.is/claim/clm_DCC0FF436A6C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_DCC0FF436A6C","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,876,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DCC0FF436A6C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2013, filed 2013-08-07"}},{"date":"2013-07-31","until":"2013-10-31","published":"2013-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,926,375,532 shares\", as of 2013-07-31 (until 2013-10-31). Claim clm_A36CCC65D836, https://asof.is/claim/clm_A36CCC65D836, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000004/0000310158-13-000004-index.htm.","url":"https://asof.is/claim/clm_A36CCC65D836","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,926,375,532 shares","status":"superseded","assertable":true,"id":"clm_A36CCC65D836","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2013, filed 2013-08-07"}},{"date":"2013-09-30","until":"2013-12-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 47,419,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_1EC02EAE4AB2, https://asof.is/claim/clm_1EC02EAE4AB2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_1EC02EAE4AB2","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"47,419,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1EC02EAE4AB2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2013, filed 2013-11-07"}},{"date":"2013-09-30","until":"2013-12-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,419,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_9EF1364229B5, https://asof.is/claim/clm_9EF1364229B5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_9EF1364229B5","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,419,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9EF1364229B5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2013, filed 2013-11-07"}},{"date":"2013-09-30","until":"2013-12-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,090,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_A29E493EA927, https://asof.is/claim/clm_A29E493EA927, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_A29E493EA927","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"14,090,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A29E493EA927","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2013, filed 2013-11-07"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,124,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_E3E08B5ED822, https://asof.is/claim/clm_E3E08B5ED822, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_E3E08B5ED822","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,124,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E3E08B5ED822","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2013, filed 2013-11-07"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,660,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_E70B4951C373, https://asof.is/claim/clm_E70B4951C373, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_E70B4951C373","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,660,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E70B4951C373","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2013, filed 2013-11-07"}},{"date":"2013-10-31","until":"2014-01-31","published":"2013-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,921,928,875 shares\", as of 2013-10-31 (until 2014-01-31). Claim clm_5DBCAF2D77B1, https://asof.is/claim/clm_5DBCAF2D77B1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015813000011/0000310158-13-000011-index.htm.","url":"https://asof.is/claim/clm_5DBCAF2D77B1","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,921,928,875 shares","status":"superseded","assertable":true,"id":"clm_5DBCAF2D77B1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2013, filed 2013-11-07"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,645,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_18DE3EDE6596, https://asof.is/claim/clm_18DE3EDE6596, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_18DE3EDE6596","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"105,645,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_18DE3EDE6596","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-27"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 7,503,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_229317196120, https://asof.is/claim/clm_229317196120, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_229317196120","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"7,503,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_229317196120","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2013, filed 2014-02-27"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 49,765,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_A0F5C187BF3E, https://asof.is/claim/clm_A0F5C187BF3E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_A0F5C187BF3E","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"49,765,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A0F5C187BF3E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2013, filed 2014-02-27"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 15,621,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_A5D39D3E54E7, https://asof.is/claim/clm_A5D39D3E54E7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_A5D39D3E54E7","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"15,621,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A5D39D3E54E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-27"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 4,404,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_E27BC8C8DD77, https://asof.is/claim/clm_E27BC8C8DD77, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_E27BC8C8DD77","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"4,404,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E27BC8C8DD77","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2013, filed 2014-02-27"}},{"date":"2014-01-31","until":"2014-04-30","published":"2014-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,940,622,461 shares\", as of 2014-01-31 (until 2014-04-30). Claim clm_2416DCFDB05C, https://asof.is/claim/clm_2416DCFDB05C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000009/0000310158-14-000009-index.htm.","url":"https://asof.is/claim/clm_2416DCFDB05C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,940,622,461 shares","status":"superseded","assertable":true,"id":"clm_2416DCFDB05C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2013, filed 2014-02-27"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,574,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_05F2BFB4125E, https://asof.is/claim/clm_05F2BFB4125E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_05F2BFB4125E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,574,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_05F2BFB4125E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2014, filed 2014-05-08"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 15,828,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_210F97389E0B, https://asof.is/claim/clm_210F97389E0B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_210F97389E0B","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"15,828,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_210F97389E0B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2014, filed 2014-05-08"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 49,975,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_8BA31BB74F0A, https://asof.is/claim/clm_8BA31BB74F0A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_8BA31BB74F0A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"49,975,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8BA31BB74F0A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2014, filed 2014-05-08"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 108,460,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_A09FA8993177, https://asof.is/claim/clm_A09FA8993177, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_A09FA8993177","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"108,460,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A09FA8993177","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2014, filed 2014-05-08"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,705,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_E212531659DD, https://asof.is/claim/clm_E212531659DD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_E212531659DD","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,705,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E212531659DD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2014, filed 2014-05-08"}},{"date":"2014-04-30","until":"2014-07-31","published":"2014-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,922,376,244 shares\", as of 2014-04-30 (until 2014-07-31). Claim clm_E265F2EB9492, https://asof.is/claim/clm_E265F2EB9492, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000033/0000310158-14-000033-index.htm.","url":"https://asof.is/claim/clm_E265F2EB9492","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,922,376,244 shares","status":"superseded","assertable":true,"id":"clm_E265F2EB9492","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2014, filed 2014-05-08"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,664,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_911F877CC3E3, https://asof.is/claim/clm_911F877CC3E3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_911F877CC3E3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,664,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_911F877CC3E3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2014, filed 2014-08-07"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 48,358,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_94E54F01B864, https://asof.is/claim/clm_94E54F01B864, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_94E54F01B864","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"48,358,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_94E54F01B864","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2014, filed 2014-08-07"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,743,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_C51678D27969, https://asof.is/claim/clm_C51678D27969, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_C51678D27969","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"9,743,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C51678D27969","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2014, filed 2014-08-07"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 97,860,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_C6D2D1307E74, https://asof.is/claim/clm_C6D2D1307E74, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_C6D2D1307E74","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"97,860,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C6D2D1307E74","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2014, filed 2014-08-07"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,004,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_F00D1BA511E6, https://asof.is/claim/clm_F00D1BA511E6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_F00D1BA511E6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"2,004,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F00D1BA511E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2014, filed 2014-08-07"}},{"date":"2014-07-31","until":"2014-10-31","published":"2014-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,884,632,033 shares\", as of 2014-07-31 (until 2014-10-31). Claim clm_5853AEBD7F61, https://asof.is/claim/clm_5853AEBD7F61, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000063/0000310158-14-000063-index.htm.","url":"https://asof.is/claim/clm_5853AEBD7F61","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,884,632,033 shares","status":"superseded","assertable":true,"id":"clm_5853AEBD7F61","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2014, filed 2014-08-07"}},{"date":"2014-09-30","until":"2014-12-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 101,808,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_3A6CAF21DAAA, https://asof.is/claim/clm_3A6CAF21DAAA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_3A6CAF21DAAA","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"101,808,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3A6CAF21DAAA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2014, filed 2014-11-10"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,659,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_49837366C97C, https://asof.is/claim/clm_49837366C97C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_49837366C97C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,659,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49837366C97C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2014, filed 2014-11-10"}},{"date":"2014-09-30","until":"2014-12-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,370,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_62E7AB824032, https://asof.is/claim/clm_62E7AB824032, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_62E7AB824032","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"11,370,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_62E7AB824032","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2014, filed 2014-11-10"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 895,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_693AD5707AD7, https://asof.is/claim/clm_693AD5707AD7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_693AD5707AD7","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"895,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_693AD5707AD7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2014, filed 2014-11-10"}},{"date":"2014-09-30","until":"2014-12-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 45,224,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_89371CE7088F, https://asof.is/claim/clm_89371CE7088F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_89371CE7088F","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"45,224,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_89371CE7088F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2014, filed 2014-11-10"}},{"date":"2014-10-31","until":"2015-01-31","published":"2014-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,850,873,371 shares\", as of 2014-10-31 (until 2015-01-31). Claim clm_F28C55B6A7FE, https://asof.is/claim/clm_F28C55B6A7FE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015814000071/0000310158-14-000071-index.htm.","url":"https://asof.is/claim/clm_F28C55B6A7FE","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,850,873,371 shares","status":"superseded","assertable":true,"id":"clm_F28C55B6A7FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2014, filed 2014-11-10"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 48,647,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_0E5197A56A4E, https://asof.is/claim/clm_0E5197A56A4E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_0E5197A56A4E","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"48,647,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0E5197A56A4E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-27"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 98,335,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_18E23DA639C2, https://asof.is/claim/clm_18E23DA639C2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_18E23DA639C2","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"98,335,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_18E23DA639C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-27"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 11,920,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_480EA42C5F46, https://asof.is/claim/clm_480EA42C5F46, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_480EA42C5F46","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"11,920,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_480EA42C5F46","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2014, filed 2015-02-27"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 7,180,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_7B46759F0E5E, https://asof.is/claim/clm_7B46759F0E5E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_7B46759F0E5E","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"7,180,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7B46759F0E5E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2014, filed 2015-02-27"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,441,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_89F2FC090FA9, https://asof.is/claim/clm_89F2FC090FA9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_89F2FC090FA9","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,441,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_89F2FC090FA9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-27"}},{"date":"2015-01-31","until":"2015-04-30","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,838,192,933 shares\", as of 2015-01-31 (until 2015-04-30). Claim clm_3B9D279D2011, https://asof.is/claim/clm_3B9D279D2011, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000005/0000310158-15-000005-index.htm.","url":"https://asof.is/claim/clm_3B9D279D2011","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,838,192,933 shares","status":"superseded","assertable":true,"id":"clm_3B9D279D2011","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2014, filed 2015-02-27"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 47,765,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_22FB10ADCE7F, https://asof.is/claim/clm_22FB10ADCE7F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_22FB10ADCE7F","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"47,765,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_22FB10ADCE7F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2015, filed 2015-05-07"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 108,345,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_3053C11D0C03, https://asof.is/claim/clm_3053C11D0C03, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_3053C11D0C03","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"108,345,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3053C11D0C03","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2015, filed 2015-05-07"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,980,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_49402CF1E6AD, https://asof.is/claim/clm_49402CF1E6AD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_49402CF1E6AD","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,980,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49402CF1E6AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2015, filed 2015-05-07"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,737,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_B147AAA7DA5F, https://asof.is/claim/clm_B147AAA7DA5F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_B147AAA7DA5F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,737,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B147AAA7DA5F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2015, filed 2015-05-07"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 953,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_EA4D3DE6DF4C, https://asof.is/claim/clm_EA4D3DE6DF4C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_EA4D3DE6DF4C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"953,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EA4D3DE6DF4C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-07"}},{"date":"2015-04-30","until":"2015-07-31","published":"2015-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,825,221,749 shares\", as of 2015-04-30 (until 2015-07-31). Claim clm_14F0931A2C29, https://asof.is/claim/clm_14F0931A2C29, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000008/0000310158-15-000008-index.htm.","url":"https://asof.is/claim/clm_14F0931A2C29","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,825,221,749 shares","status":"superseded","assertable":true,"id":"clm_14F0931A2C29","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2015, filed 2015-05-07"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,670,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_19CFD7F8FB0B, https://asof.is/claim/clm_19CFD7F8FB0B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_19CFD7F8FB0B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,670,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_19CFD7F8FB0B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2015, filed 2015-08-06"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 102,582,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_1A67A4E05244, https://asof.is/claim/clm_1A67A4E05244, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_1A67A4E05244","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"102,582,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A67A4E05244","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2015, filed 2015-08-06"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 46,448,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_39A0C18651A0, https://asof.is/claim/clm_39A0C18651A0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_39A0C18651A0","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"46,448,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39A0C18651A0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2015, filed 2015-08-06"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 687,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_580CDBD2CB5C, https://asof.is/claim/clm_580CDBD2CB5C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_580CDBD2CB5C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"687,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_580CDBD2CB5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2015, filed 2015-08-06"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,922,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_6919D2A6E878, https://asof.is/claim/clm_6919D2A6E878, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_6919D2A6E878","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,922,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6919D2A6E878","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2015, filed 2015-08-06"}},{"date":"2015-07-31","until":"2015-10-31","published":"2015-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,816,635,020 shares\", as of 2015-07-31 (until 2015-10-31). Claim clm_53616B87641B, https://asof.is/claim/clm_53616B87641B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000053/0000310158-15-000053-index.htm.","url":"https://asof.is/claim/clm_53616B87641B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,816,635,020 shares","status":"superseded","assertable":true,"id":"clm_53616B87641B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2015, filed 2015-08-06"}},{"date":"2015-09-30","until":"2015-12-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 45,587,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_15359FB5299B, https://asof.is/claim/clm_15359FB5299B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_15359FB5299B","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"45,587,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_15359FB5299B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2015, filed 2015-11-05"}},{"date":"2015-09-30","until":"2015-12-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,548,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_59257E5213FA, https://asof.is/claim/clm_59257E5213FA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_59257E5213FA","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,548,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59257E5213FA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-11-05"}},{"date":"2015-09-30","until":"2015-12-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 101,232,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_A47DE2B24AF2, https://asof.is/claim/clm_A47DE2B24AF2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_A47DE2B24AF2","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"101,232,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A47DE2B24AF2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2015, filed 2015-11-05"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,500,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_AC2912FEAAED, https://asof.is/claim/clm_AC2912FEAAED, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_AC2912FEAAED","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,500,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AC2912FEAAED","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2015, filed 2015-11-05"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,826,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_CDDC90397241, https://asof.is/claim/clm_CDDC90397241, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_CDDC90397241","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,826,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CDDC90397241","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2015, filed 2015-11-05"}},{"date":"2015-10-31","until":"2016-01-31","published":"2015-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,793,543,137 shares\", as of 2015-10-31 (until 2016-01-31). Claim clm_1C1225C23E40, https://asof.is/claim/clm_1C1225C23E40, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015815000058/0000310158-15-000058-index.htm.","url":"https://asof.is/claim/clm_1C1225C23E40","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,793,543,137 shares","status":"superseded","assertable":true,"id":"clm_1C1225C23E40","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2015, filed 2015-11-05"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 4,442,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_5192469BE119, https://asof.is/claim/clm_5192469BE119, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_5192469BE119","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"4,442,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5192469BE119","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2016-02-26"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,524,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_7BDCD397A17D, https://asof.is/claim/clm_7BDCD397A17D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_7BDCD397A17D","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,524,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7BDCD397A17D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-26"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 6,704,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_D52E6DA72BE9, https://asof.is/claim/clm_D52E6DA72BE9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_D52E6DA72BE9","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"6,704,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D52E6DA72BE9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2015, filed 2016-02-26"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,676,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_F89730A7CEBD, https://asof.is/claim/clm_F89730A7CEBD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_F89730A7CEBD","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"44,676,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F89730A7CEBD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2016-02-26"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 101,779,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_FEF2D6BB7989, https://asof.is/claim/clm_FEF2D6BB7989, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_FEF2D6BB7989","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"101,779,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FEF2D6BB7989","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-26"}},{"date":"2016-01-31","until":"2016-04-30","published":"2016-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,775,258,591 shares\", as of 2016-01-31 (until 2016-04-30). Claim clm_3AABB9FFA15E, https://asof.is/claim/clm_3AABB9FFA15E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000063/0000310158-16-000063-index.htm.","url":"https://asof.is/claim/clm_3AABB9FFA15E","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,775,258,591 shares","status":"superseded","assertable":true,"id":"clm_3AABB9FFA15E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2015, filed 2016-02-26"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 98,755,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_288991751ADB, https://asof.is/claim/clm_288991751ADB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_288991751ADB","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"98,755,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_288991751ADB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2016, filed 2016-05-09"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,716,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_825172ED4990, https://asof.is/claim/clm_825172ED4990, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_825172ED4990","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"9,716,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_825172ED4990","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2016-05-09"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,125,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_85649A72C697, https://asof.is/claim/clm_85649A72C697, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_85649A72C697","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,125,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_85649A72C697","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2016-05-09"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,659,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_D488C57B0FAA, https://asof.is/claim/clm_D488C57B0FAA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_D488C57B0FAA","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,659,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D488C57B0FAA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2016, filed 2016-05-09"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,806,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_D96A931644FC, https://asof.is/claim/clm_D96A931644FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_D96A931644FC","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"43,806,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D96A931644FC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2016, filed 2016-05-09"}},{"date":"2016-04-30","until":"2016-07-31","published":"2016-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,768,025,348 shares\", as of 2016-04-30 (until 2016-07-31). Claim clm_76492752CBD6, https://asof.is/claim/clm_76492752CBD6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000066/0000310158-16-000066-index.htm.","url":"https://asof.is/claim/clm_76492752CBD6","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,768,025,348 shares","status":"superseded","assertable":true,"id":"clm_76492752CBD6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2016, filed 2016-05-09"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,151,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_4FDF2F5B4857, https://asof.is/claim/clm_4FDF2F5B4857, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_4FDF2F5B4857","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,151,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4FDF2F5B4857","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2016, filed 2016-08-08"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,357,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_86A8CB1D7187, https://asof.is/claim/clm_86A8CB1D7187, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_86A8CB1D7187","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"43,357,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_86A8CB1D7187","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2016-08-08"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,608,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_A89A271BF7E1, https://asof.is/claim/clm_A89A271BF7E1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_A89A271BF7E1","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,608,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A89A271BF7E1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2016-08-08"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,205,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_C2D709880E62, https://asof.is/claim/clm_C2D709880E62, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_C2D709880E62","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,205,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C2D709880E62","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2016-08-08"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 96,475,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_CFF0D674C75A, https://asof.is/claim/clm_CFF0D674C75A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_CFF0D674C75A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"96,475,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CFF0D674C75A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2016, filed 2016-08-08"}},{"date":"2016-07-31","until":"2016-10-31","published":"2016-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,765,208,203 shares\", as of 2016-07-31 (until 2016-10-31). Claim clm_42D5BA4A587B, https://asof.is/claim/clm_42D5BA4A587B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000094/0000310158-16-000094-index.htm.","url":"https://asof.is/claim/clm_42D5BA4A587B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,765,208,203 shares","status":"superseded","assertable":true,"id":"clm_42D5BA4A587B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2016-08-08"}},{"date":"2016-09-30","until":"2016-12-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,907,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_437CAECBFA51, https://asof.is/claim/clm_437CAECBFA51, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_437CAECBFA51","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,907,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_437CAECBFA51","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2016, filed 2016-11-07"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,184,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_8C42F3B5F24C, https://asof.is/claim/clm_8C42F3B5F24C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_8C42F3B5F24C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"2,184,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8C42F3B5F24C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2016, filed 2016-11-07"}},{"date":"2016-09-30","until":"2016-12-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,744,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_96D16DB08BF3, https://asof.is/claim/clm_96D16DB08BF3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_96D16DB08BF3","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"43,744,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_96D16DB08BF3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-11-07"}},{"date":"2016-09-30","until":"2016-12-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 98,335,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_CEE60B020EE0, https://asof.is/claim/clm_CEE60B020EE0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_CEE60B020EE0","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"98,335,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CEE60B020EE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2016, filed 2016-11-07"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,664,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_E2DBCCAAB311, https://asof.is/claim/clm_E2DBCCAAB311, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_E2DBCCAAB311","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,664,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E2DBCCAAB311","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2016, filed 2016-11-07"}},{"date":"2016-10-31","until":"2017-01-31","published":"2016-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,757,137,517 shares\", as of 2016-10-31 (until 2017-01-31). Claim clm_9225D2BB085B, https://asof.is/claim/clm_9225D2BB085B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015816000098/0000310158-16-000098-index.htm.","url":"https://asof.is/claim/clm_9225D2BB085B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,757,137,517 shares","status":"superseded","assertable":true,"id":"clm_9225D2BB085B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2016, filed 2016-11-07"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,515,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_296D7E29A85C, https://asof.is/claim/clm_296D7E29A85C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_296D7E29A85C","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,515,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_296D7E29A85C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-28"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 3,920,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_2F97411688D4, https://asof.is/claim/clm_2F97411688D4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_2F97411688D4","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,920,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2F97411688D4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-28"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 10,124,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_8B7063543990, https://asof.is/claim/clm_8B7063543990, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_8B7063543990","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"10,124,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B7063543990","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2016, filed 2017-02-28"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 95,377,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_9C0CF77D801C, https://asof.is/claim/clm_9C0CF77D801C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_9C0CF77D801C","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"95,377,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9C0CF77D801C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-28"}},{"date":"2016-12-31","until":"2017-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 39,807,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_B3973E2ADB22, https://asof.is/claim/clm_B3973E2ADB22, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_B3973E2ADB22","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"39,807,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B3973E2ADB22","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-27"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 40,088,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_F4558D2EB9F0, https://asof.is/claim/clm_F4558D2EB9F0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_F4558D2EB9F0","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"40,088,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F4558D2EB9F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2016, filed 2017-02-28"}},{"date":"2017-01-31","until":"2017-04-30","published":"2017-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,745,571,067 shares\", as of 2017-01-31 (until 2017-04-30). Claim clm_3E4686F1C38B, https://asof.is/claim/clm_3E4686F1C38B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000010/0000310158-17-000010-index.htm.","url":"https://asof.is/claim/clm_3E4686F1C38B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,745,571,067 shares","status":"superseded","assertable":true,"id":"clm_3E4686F1C38B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2016, filed 2017-02-28"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,551,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_0CA94408597F, https://asof.is/claim/clm_0CA94408597F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_0CA94408597F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,551,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0CA94408597F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-09"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,708,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_372309F7322C, https://asof.is/claim/clm_372309F7322C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_372309F7322C","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"11,708,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_372309F7322C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2017, filed 2017-05-09"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 39,837,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_8BB7754D3964, https://asof.is/claim/clm_8BB7754D3964, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_8BB7754D3964","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"39,837,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8BB7754D3964","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2017, filed 2017-05-09"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 96,561,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_92759280B530, https://asof.is/claim/clm_92759280B530, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_92759280B530","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"96,561,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_92759280B530","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2017, filed 2017-05-09"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,796,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_E6943054D4C9, https://asof.is/claim/clm_E6943054D4C9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_E6943054D4C9","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,796,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E6943054D4C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2017, filed 2017-05-09"}},{"date":"2017-04-30","until":"2017-07-31","published":"2017-05-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,735,164,510 shares\", as of 2017-04-30 (until 2017-07-31). Claim clm_17404A75E250, https://asof.is/claim/clm_17404A75E250, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000016/0000310158-17-000016-index.htm.","url":"https://asof.is/claim/clm_17404A75E250","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,735,164,510 shares","status":"superseded","assertable":true,"id":"clm_17404A75E250","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2017-05-09"}},{"date":"2017-06-30","until":"2017-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 9,930,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_02E1EC40EBB1, https://asof.is/claim/clm_02E1EC40EBB1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_02E1EC40EBB1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"9,930,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_02E1EC40EBB1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2018, filed 2018-08-07"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,786,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_069AC1ED0F10, https://asof.is/claim/clm_069AC1ED0F10, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_069AC1ED0F10","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,786,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_069AC1ED0F10","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,749,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_3B507E46CC5D, https://asof.is/claim/clm_3B507E46CC5D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_3B507E46CC5D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,749,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3B507E46CC5D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,946,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_4DB34C3A4F05, https://asof.is/claim/clm_4DB34C3A4F05, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_4DB34C3A4F05","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,946,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4DB34C3A4F05","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 39,463,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_868E075D6D61, https://asof.is/claim/clm_868E075D6D61, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_868E075D6D61","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"39,463,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_868E075D6D61","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 92,804,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_8BFD8488B3A5, https://asof.is/claim/clm_8BFD8488B3A5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_8BFD8488B3A5","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"92,804,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8BFD8488B3A5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-07-31","until":"2017-10-31","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,727,354,340 shares\", as of 2017-07-31 (until 2017-10-31). Claim clm_EEE6786E9E9E, https://asof.is/claim/clm_EEE6786E9E9E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000037/0000310158-17-000037-index.htm.","url":"https://asof.is/claim/clm_EEE6786E9E9E","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,727,354,340 shares","status":"superseded","assertable":true,"id":"clm_EEE6786E9E9E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-09-30","until":"2017-12-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 38,248,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_207F5C0875B9, https://asof.is/claim/clm_207F5C0875B9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_207F5C0875B9","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"38,248,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_207F5C0875B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2017, filed 2017-11-07"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,383,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_393DB4682B31, https://asof.is/claim/clm_393DB4682B31, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_393DB4682B31","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"4,383,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_393DB4682B31","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2017, filed 2017-11-07"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: -56,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_B00F52FDD238, https://asof.is/claim/clm_B00F52FDD238, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_B00F52FDD238","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"-56,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B00F52FDD238","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-07"}},{"date":"2017-09-30","until":"2017-12-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,901,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_B47A627983F0, https://asof.is/claim/clm_B47A627983F0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_B47A627983F0","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,901,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B47A627983F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2017, filed 2017-11-07"}},{"date":"2017-09-30","until":"2017-12-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 91,676,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_C6F722C9950C, https://asof.is/claim/clm_C6F722C9950C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_C6F722C9950C","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,676,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C6F722C9950C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2017, filed 2017-11-07"}},{"date":"2017-09-30","until":"2018-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,325,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_CE4B75CB7BCE, https://asof.is/claim/clm_CE4B75CB7BCE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_CE4B75CB7BCE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"10,325,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CE4B75CB7BCE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2017-10-31","until":"2018-01-31","published":"2017-11-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,724,436,835 shares\", as of 2017-10-31 (until 2018-01-31). Claim clm_9F2CDB05F1E9, https://asof.is/claim/clm_9F2CDB05F1E9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015817000045/0000310158-17-000045-index.htm.","url":"https://asof.is/claim/clm_9F2CDB05F1E9","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,724,436,835 shares","status":"superseded","assertable":true,"id":"clm_9F2CDB05F1E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2017, filed 2017-11-07"}},{"date":"2017-12-31","until":"2018-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 40,122,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_1145C38DDEF9, https://asof.is/claim/clm_1145C38DDEF9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_1145C38DDEF9","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"40,122,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1145C38DDEF9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-27"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,092,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_232F37648DD2, https://asof.is/claim/clm_232F37648DD2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_232F37648DD2","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,092,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_232F37648DD2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-27"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 87,872,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_2BFBBD91DD20, https://asof.is/claim/clm_2BFBBD91DD20, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_2BFBBD91DD20","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"87,872,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2BFBBD91DD20","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-27"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 34,336,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_BC24AF78EFCB, https://asof.is/claim/clm_BC24AF78EFCB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_BC24AF78EFCB","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"34,336,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BC24AF78EFCB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2017, filed 2018-02-27"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 10,208,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_C217AE3D4BB6, https://asof.is/claim/clm_C217AE3D4BB6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_C217AE3D4BB6","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"10,208,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C217AE3D4BB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2017, filed 2018-02-27"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 2,394,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_C317F9A41D65, https://asof.is/claim/clm_C317F9A41D65, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_C317F9A41D65","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"2,394,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C317F9A41D65","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2018-02-27"}},{"date":"2018-01-31","until":"2018-04-30","published":"2018-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,696,190,502 shares\", as of 2018-01-31 (until 2018-04-30). Claim clm_EE7BE5F78BEA, https://asof.is/claim/clm_EE7BE5F78BEA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000005/0000310158-18-000005-index.htm.","url":"https://asof.is/claim/clm_EE7BE5F78BEA","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,696,190,502 shares","status":"superseded","assertable":true,"id":"clm_EE7BE5F78BEA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2017, filed 2018-02-27"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 33,668,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_600C98D7D769, https://asof.is/claim/clm_600C98D7D769, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_600C98D7D769","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"33,668,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_600C98D7D769","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2018-05-08"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,196,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_72F018D1F42C, https://asof.is/claim/clm_72F018D1F42C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_72F018D1F42C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"3,196,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72F018D1F42C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2018, filed 2018-05-08"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 86,041,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_B05C96267A31, https://asof.is/claim/clm_B05C96267A31, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_B05C96267A31","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"86,041,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B05C96267A31","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2018, filed 2018-05-08"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 4,483,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_C199DABE1F23, https://asof.is/claim/clm_C199DABE1F23, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_C199DABE1F23","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,483,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C199DABE1F23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2018-05-08"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 736,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_D25BE24533C1, https://asof.is/claim/clm_D25BE24533C1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_D25BE24533C1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"736,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D25BE24533C1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2018-05-08"}},{"date":"2018-03-31","until":"2018-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,037,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_E8AC27AFE10B, https://asof.is/claim/clm_E8AC27AFE10B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_E8AC27AFE10B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"10,037,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E8AC27AFE10B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-05-08"}},{"date":"2018-04-30","until":"2018-07-31","published":"2018-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,690,303,898 shares\", as of 2018-04-30 (until 2018-07-31). Claim clm_5CB49AA3F905, https://asof.is/claim/clm_5CB49AA3F905, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000011/0000310158-18-000011-index.htm.","url":"https://asof.is/claim/clm_5CB49AA3F905","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,690,303,898 shares","status":"superseded","assertable":true,"id":"clm_5CB49AA3F905","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2018, filed 2018-05-08"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 85,040,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_00D624D3F6C6, https://asof.is/claim/clm_00D624D3F6C6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_00D624D3F6C6","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"85,040,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_00D624D3F6C6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2018, filed 2018-08-07"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,310,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_AAA255A07687, https://asof.is/claim/clm_AAA255A07687, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_AAA255A07687","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"5,310,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AAA255A07687","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2018, filed 2018-08-07"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,707,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_B18491AB2F19, https://asof.is/claim/clm_B18491AB2F19, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_B18491AB2F19","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,707,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B18491AB2F19","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2018, filed 2018-08-07"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 32,529,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_BF9BD7C5474F, https://asof.is/claim/clm_BF9BD7C5474F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_BF9BD7C5474F","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"32,529,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF9BD7C5474F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2018, filed 2018-08-07"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,465,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_EAA01F078C81, https://asof.is/claim/clm_EAA01F078C81, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_EAA01F078C81","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"10,465,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EAA01F078C81","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2018, filed 2018-08-07"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,274,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_FD39BFA827F7, https://asof.is/claim/clm_FD39BFA827F7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_FD39BFA827F7","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,274,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FD39BFA827F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2018, filed 2018-08-07"}},{"date":"2018-07-31","until":"2018-10-31","published":"2018-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,659,525,311 shares\", as of 2018-07-31 (until 2018-10-31). Claim clm_0629D11AC216, https://asof.is/claim/clm_0629D11AC216, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000034/0000310158-18-000034-index.htm.","url":"https://asof.is/claim/clm_0629D11AC216","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,659,525,311 shares","status":"superseded","assertable":true,"id":"clm_0629D11AC216","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2018, filed 2018-08-07"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,068,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_2724E09F4094, https://asof.is/claim/clm_2724E09F4094, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_2724E09F4094","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,068,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2724E09F4094","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 32,422,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_59E105928DAD, https://asof.is/claim/clm_59E105928DAD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_59E105928DAD","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"32,422,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59E105928DAD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,826,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_B3CC449D09A5, https://asof.is/claim/clm_B3CC449D09A5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_B3CC449D09A5","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,826,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B3CC449D09A5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,794,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_E5380D65707D, https://asof.is/claim/clm_E5380D65707D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_E5380D65707D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"10,794,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E5380D65707D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 85,130,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_F3A459B65CBF, https://asof.is/claim/clm_F3A459B65CBF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_F3A459B65CBF","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"85,130,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F3A459B65CBF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,950,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_FC96B547649A, https://asof.is/claim/clm_FC96B547649A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_FC96B547649A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,950,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC96B547649A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-10-31","until":"2019-01-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,600,376,500 shares\", as of 2018-10-31 (until 2019-01-31). Claim clm_F1CB002B7759, https://asof.is/claim/clm_F1CB002B7759, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015818000039/0000310158-18-000039-index.htm.","url":"https://asof.is/claim/clm_F1CB002B7759","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,600,376,500 shares","status":"superseded","assertable":true,"id":"clm_F1CB002B7759","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 82,637,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_6CE3449E9C0D, https://asof.is/claim/clm_6CE3449E9C0D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_6CE3449E9C0D","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"82,637,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6CE3449E9C0D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-27"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 9,752,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_781231FF91DC, https://asof.is/claim/clm_781231FF91DC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_781231FF91DC","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"9,752,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_781231FF91DC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2018, filed 2019-02-27"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 42,294,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_829CCD9C74BC, https://asof.is/claim/clm_829CCD9C74BC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_829CCD9C74BC","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"42,294,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_829CCD9C74BC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-27"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,965,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_C4B47494D086, https://asof.is/claim/clm_C4B47494D086, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_C4B47494D086","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,965,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4B47494D086","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-27"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 6,220,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_D1FFB154F0E4, https://asof.is/claim/clm_D1FFB154F0E4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_D1FFB154F0E4","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"6,220,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D1FFB154F0E4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2019-02-27"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 26,701,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_E57111F73208, https://asof.is/claim/clm_E57111F73208, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_E57111F73208","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"26,701,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E57111F73208","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2018, filed 2019-02-27"}},{"date":"2019-01-31","until":"2019-04-30","published":"2019-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,581,220,308 shares\", as of 2019-01-31 (until 2019-04-30). Claim clm_9AEDFCF6FFF1, https://asof.is/claim/clm_9AEDFCF6FFF1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000014/0000310158-19-000014-index.htm.","url":"https://asof.is/claim/clm_9AEDFCF6FFF1","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,581,220,308 shares","status":"superseded","assertable":true,"id":"clm_9AEDFCF6FFF1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2018, filed 2019-02-27"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 82,354,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_296C5FD003C5, https://asof.is/claim/clm_296C5FD003C5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_296C5FD003C5","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"82,354,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_296C5FD003C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2019, filed 2019-05-08"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 1,931,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_3122AF3523E0, https://asof.is/claim/clm_3122AF3523E0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_3122AF3523E0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"1,931,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3122AF3523E0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2019, filed 2019-05-08"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 27,539,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_7CB401BF90C0, https://asof.is/claim/clm_7CB401BF90C0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_7CB401BF90C0","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"27,539,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7CB401BF90C0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2019, filed 2019-05-08"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,816,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_800327091376, https://asof.is/claim/clm_800327091376, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_800327091376","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"10,816,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_800327091376","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-05-08"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,076,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_BA62E6A9ABE6, https://asof.is/claim/clm_BA62E6A9ABE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_BA62E6A9ABE6","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,076,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BA62E6A9ABE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2019, filed 2019-05-08"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,915,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_F508DB33EABE, https://asof.is/claim/clm_F508DB33EABE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_F508DB33EABE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"2,915,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F508DB33EABE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2019, filed 2019-05-08"}},{"date":"2019-04-30","until":"2019-07-31","published":"2019-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,574,644,410 shares\", as of 2019-04-30 (until 2019-07-31). Claim clm_45D07EF51ABE, https://asof.is/claim/clm_45D07EF51ABE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000019/0000310158-19-000019-index.htm.","url":"https://asof.is/claim/clm_45D07EF51ABE","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,574,644,410 shares","status":"superseded","assertable":true,"id":"clm_45D07EF51ABE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2019, filed 2019-05-08"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 83,965,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_07EDDEDB6853, https://asof.is/claim/clm_07EDDEDB6853, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_07EDDEDB6853","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"83,965,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_07EDDEDB6853","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2019, filed 2019-08-06"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,670,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_104F474E5C73, https://asof.is/claim/clm_104F474E5C73, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_104F474E5C73","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"2,670,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_104F474E5C73","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2019-08-06"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,760,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_25A17B48A15F, https://asof.is/claim/clm_25A17B48A15F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_25A17B48A15F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"11,760,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_25A17B48A15F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2019, filed 2019-08-06"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 27,635,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_3F564403AA3B, https://asof.is/claim/clm_3F564403AA3B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_3F564403AA3B","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"27,635,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3F564403AA3B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2019, filed 2019-08-06"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,659,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_EB2F3D5D01EC, https://asof.is/claim/clm_EB2F3D5D01EC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_EB2F3D5D01EC","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,659,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EB2F3D5D01EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2019, filed 2019-08-06"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,189,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_FE9AB4A6BF09, https://asof.is/claim/clm_FE9AB4A6BF09, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_FE9AB4A6BF09","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,189,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FE9AB4A6BF09","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2019, filed 2019-08-06"}},{"date":"2019-07-31","until":"2019-10-31","published":"2019-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,560,374,643 shares\", as of 2019-07-31 (until 2019-10-31). Claim clm_24A63371969B, https://asof.is/claim/clm_24A63371969B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000037/0000310158-19-000037-index.htm.","url":"https://asof.is/claim/clm_24A63371969B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,560,374,643 shares","status":"superseded","assertable":true,"id":"clm_24A63371969B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2019, filed 2019-08-06"}},{"date":"2019-09-30","until":"2019-12-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,869,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_13B057D601E9, https://asof.is/claim/clm_13B057D601E9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_13B057D601E9","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,869,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_13B057D601E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2019, filed 2019-11-05"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 12,397,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_3AE77590962D, https://asof.is/claim/clm_3AE77590962D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_3AE77590962D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"12,397,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3AE77590962D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2019, filed 2019-11-05"}},{"date":"2019-09-30","until":"2019-12-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 26,838,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_7CE9BE85C914, https://asof.is/claim/clm_7CE9BE85C914, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_7CE9BE85C914","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"26,838,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7CE9BE85C914","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2019, filed 2019-11-05"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,204,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_B868BDC6CD31, https://asof.is/claim/clm_B868BDC6CD31, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_B868BDC6CD31","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"3,204,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B868BDC6CD31","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2019, filed 2019-11-05"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,901,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_C49B13FDDF3A, https://asof.is/claim/clm_C49B13FDDF3A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_C49B13FDDF3A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,901,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C49B13FDDF3A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-11-05"}},{"date":"2019-09-30","until":"2019-12-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 83,331,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_DF0DF5E31A2D, https://asof.is/claim/clm_DF0DF5E31A2D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_DF0DF5E31A2D","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"83,331,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DF0DF5E31A2D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-11-05"}},{"date":"2019-10-31","until":"2020-01-31","published":"2019-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,545,984,142 shares\", as of 2019-10-31 (until 2020-01-31). Claim clm_EC29FB8F343C, https://asof.is/claim/clm_EC29FB8F343C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015819000042/0000310158-19-000042-index.htm.","url":"https://asof.is/claim/clm_EC29FB8F343C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,545,984,142 shares","status":"superseded","assertable":true,"id":"clm_EC29FB8F343C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2019, filed 2019-11-05"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 84,397,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_029900C42A81, https://asof.is/claim/clm_029900C42A81, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_029900C42A81","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"84,397,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_029900C42A81","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-26"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 25,907,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_51169445BDC3, https://asof.is/claim/clm_51169445BDC3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_51169445BDC3","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"25,907,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_51169445BDC3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2020-02-26"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 46,840,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_72B03D5517FF, https://asof.is/claim/clm_72B03D5517FF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_72B03D5517FF","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"46,840,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72B03D5517FF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2019, filed 2020-02-26"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 9,843,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_97E52B2371D0, https://asof.is/claim/clm_97E52B2371D0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_97E52B2371D0","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"9,843,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97E52B2371D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2020-02-26"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 9,872,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_D5BC12D2484C, https://asof.is/claim/clm_D5BC12D2484C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_D5BC12D2484C","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"9,872,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D5BC12D2484C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2019, filed 2020-02-26"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,676,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_F75263B1D61F, https://asof.is/claim/clm_F75263B1D61F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_F75263B1D61F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"9,676,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F75263B1D61F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-26"}},{"date":"2020-01-31","until":"2020-04-30","published":"2020-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,536,268,760 shares\", as of 2020-01-31 (until 2020-04-30). Claim clm_B554111539E4, https://asof.is/claim/clm_B554111539E4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000005/0000310158-20-000005-index.htm.","url":"https://asof.is/claim/clm_B554111539E4","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,536,268,760 shares","status":"superseded","assertable":true,"id":"clm_B554111539E4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2019, filed 2020-02-26"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,219,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_1A9DF101A4EB, https://asof.is/claim/clm_1A9DF101A4EB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_1A9DF101A4EB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"3,219,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A9DF101A4EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 84,913,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_2A9BC3DD361F, https://asof.is/claim/clm_2A9BC3DD361F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_2A9BC3DD361F","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"84,913,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A9BC3DD361F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,425,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_2F02734188EA, https://asof.is/claim/clm_2F02734188EA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_2F02734188EA","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,425,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2F02734188EA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,209,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_5596F1B23FD3, https://asof.is/claim/clm_5596F1B23FD3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_5596F1B23FD3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,209,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5596F1B23FD3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 26,205,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_8230E6A696F5, https://asof.is/claim/clm_8230E6A696F5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_8230E6A696F5","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"26,205,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8230E6A696F5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 12,057,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_E554AD8078D3, https://asof.is/claim/clm_E554AD8078D3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_E554AD8078D3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"12,057,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E554AD8078D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-04-30","until":"2020-07-31","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,524,101,191 shares\", as of 2020-04-30 (until 2020-07-31). Claim clm_A5759D744830, https://asof.is/claim/clm_A5759D744830, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000009/0000310158-20-000009-index.htm.","url":"https://asof.is/claim/clm_A5759D744830","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,524,101,191 shares","status":"superseded","assertable":true,"id":"clm_A5759D744830","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 27,642,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_418AA1D3C2FF, https://asof.is/claim/clm_418AA1D3C2FF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_418AA1D3C2FF","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"27,642,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_418AA1D3C2FF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 90,615,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_84481BCEF2DA, https://asof.is/claim/clm_84481BCEF2DA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_84481BCEF2DA","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,615,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_84481BCEF2DA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 10,872,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_AFC6EDCC90D8, https://asof.is/claim/clm_AFC6EDCC90D8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_AFC6EDCC90D8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"10,872,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AFC6EDCC90D8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,103,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_F0C3055A26FF, https://asof.is/claim/clm_F0C3055A26FF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_F0C3055A26FF","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"11,103,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F0C3055A26FF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,123,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_F21AC6FA6FAB, https://asof.is/claim/clm_F21AC6FA6FAB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_F21AC6FA6FAB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,123,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F21AC6FA6FAB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,002,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_F7B34F85A744, https://asof.is/claim/clm_F7B34F85A744, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_F7B34F85A744","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"3,002,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F7B34F85A744","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-07-31","until":"2020-10-31","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,529,241,070 shares\", as of 2020-07-31 (until 2020-10-31). Claim clm_26BCDBE0EE1C, https://asof.is/claim/clm_26BCDBE0EE1C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000026/0000310158-20-000026-index.htm.","url":"https://asof.is/claim/clm_26BCDBE0EE1C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,529,241,070 shares","status":"superseded","assertable":true,"id":"clm_26BCDBE0EE1C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-09-30","until":"2020-12-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 29,186,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_2214A1ACEDDD, https://asof.is/claim/clm_2214A1ACEDDD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_2214A1ACEDDD","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"29,186,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2214A1ACEDDD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-09-30","until":"2020-12-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 7,356,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_3D89E44DB40E, https://asof.is/claim/clm_3D89E44DB40E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_3D89E44DB40E","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,356,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D89E44DB40E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 12,551,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_5C1E46793168, https://asof.is/claim/clm_5C1E46793168, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_5C1E46793168","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"12,551,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C1E46793168","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,390,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_601363BB78C5, https://asof.is/claim/clm_601363BB78C5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_601363BB78C5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"3,390,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_601363BB78C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-09-30","until":"2020-12-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 89,800,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_B8D35EEE2364, https://asof.is/claim/clm_B8D35EEE2364, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_B8D35EEE2364","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"89,800,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B8D35EEE2364","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,941,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_F4D24DFDC05F, https://asof.is/claim/clm_F4D24DFDC05F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_F4D24DFDC05F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"2,941,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F4D24DFDC05F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-10-31","until":"2021-01-31","published":"2020-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,530,034,437 shares\", as of 2020-10-31 (until 2021-01-31). Claim clm_19A0DB5C39B2, https://asof.is/claim/clm_19A0DB5C39B2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015820000030/0000310158-20-000030-index.htm.","url":"https://asof.is/claim/clm_19A0DB5C39B2","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,530,034,437 shares","status":"superseded","assertable":true,"id":"clm_19A0DB5C39B2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2020, filed 2020-11-05"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 91,588,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_2D92122CFA57, https://asof.is/claim/clm_2D92122CFA57, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_2D92122CFA57","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,588,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2D92122CFA57","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-25"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,062,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_3479D27E9553, https://asof.is/claim/clm_3479D27E9553, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_3479D27E9553","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,062,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3479D27E9553","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-25"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 13,558,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_6003F5963D12, https://asof.is/claim/clm_6003F5963D12, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_6003F5963D12","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"13,558,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6003F5963D12","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2020, filed 2021-02-25"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 25,317,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_B923437A977E, https://asof.is/claim/clm_B923437A977E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_B923437A977E","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"25,317,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B923437A977E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2020, filed 2021-02-25"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 47,994,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_F41E55DA096F, https://asof.is/claim/clm_F41E55DA096F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_F41E55DA096F","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"47,994,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F41E55DA096F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2020, filed 2021-02-25"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 7,067,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_F81DAFAD73AE, https://asof.is/claim/clm_F81DAFAD73AE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_F81DAFAD73AE","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"7,067,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F81DAFAD73AE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2021-02-25"}},{"date":"2021-01-31","until":"2021-04-30","published":"2021-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,530,315,668 shares\", as of 2021-01-31 (until 2021-04-30). Claim clm_DB50492A0D5C, https://asof.is/claim/clm_DB50492A0D5C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/0000310158-21-000004-index.htm.","url":"https://asof.is/claim/clm_DB50492A0D5C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,530,315,668 shares","status":"superseded","assertable":true,"id":"clm_DB50492A0D5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2020, filed 2021-02-25"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 90,847,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_1D93C5758916, https://asof.is/claim/clm_1D93C5758916, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_1D93C5758916","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,847,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1D93C5758916","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2021-05-05"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 26,945,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_29418B6878C2, https://asof.is/claim/clm_29418B6878C2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_29418B6878C2","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"26,945,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_29418B6878C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2021, filed 2021-05-05"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 12,080,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_2B42EB43141D, https://asof.is/claim/clm_2B42EB43141D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_2B42EB43141D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"12,080,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2B42EB43141D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2021, filed 2021-05-05"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,981,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_2DA98D07113A, https://asof.is/claim/clm_2DA98D07113A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_2DA98D07113A","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,981,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2DA98D07113A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2021-05-05"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,465,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_602E83B5A23B, https://asof.is/claim/clm_602E83B5A23B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_602E83B5A23B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,465,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_602E83B5A23B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2021, filed 2021-05-05"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,179,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_64B45488298B, https://asof.is/claim/clm_64B45488298B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_64B45488298B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"3,179,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_64B45488298B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2021-05-05"}},{"date":"2021-04-30","until":"2021-07-31","published":"2021-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,532,058,364 shares\", as of 2021-04-30 (until 2021-07-31). Claim clm_02F25E967F12, https://asof.is/claim/clm_02F25E967F12, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000009/0000310158-21-000009-index.htm.","url":"https://asof.is/claim/clm_02F25E967F12","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,532,058,364 shares","status":"superseded","assertable":true,"id":"clm_02F25E967F12","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2021, filed 2021-05-05"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 1,545,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_0517E31C3FEB, https://asof.is/claim/clm_0517E31C3FEB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_0517E31C3FEB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,545,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0517E31C3FEB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2021-08-09"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 90,688,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_0AFE389E5C48, https://asof.is/claim/clm_0AFE389E5C48, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_0AFE389E5C48","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,688,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0AFE389E5C48","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2021-08-09"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 33,294,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_6520ACD0ED9A, https://asof.is/claim/clm_6520ACD0ED9A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_6520ACD0ED9A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"33,294,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6520ACD0ED9A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2021-08-09"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,575,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_80ED88D5B228, https://asof.is/claim/clm_80ED88D5B228, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_80ED88D5B228","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,575,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_80ED88D5B228","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2021-08-09"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,321,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_C3C0E7554FA8, https://asof.is/claim/clm_C3C0E7554FA8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_C3C0E7554FA8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"4,321,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C3C0E7554FA8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2021, filed 2021-08-09"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 11,402,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_C9956D0CFD23, https://asof.is/claim/clm_C9956D0CFD23, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_C9956D0CFD23","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"11,402,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C9956D0CFD23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2021, filed 2021-08-09"}},{"date":"2021-07-31","until":"2021-10-31","published":"2021-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,531,374,696 shares\", as of 2021-07-31 (until 2021-10-31). Claim clm_7D9AD895C751, https://asof.is/claim/clm_7D9AD895C751, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000028/0000310158-21-000028-index.htm.","url":"https://asof.is/claim/clm_7D9AD895C751","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,531,374,696 shares","status":"superseded","assertable":true,"id":"clm_7D9AD895C751","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-08-09"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 10,016,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_3A29303F7FB7, https://asof.is/claim/clm_3A29303F7FB7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_3A29303F7FB7","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"10,016,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3A29303F7FB7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-11-05"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,445,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_6271F68058A2, https://asof.is/claim/clm_6271F68058A2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_6271F68058A2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,445,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6271F68058A2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2021, filed 2021-11-05"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,567,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_7124FBE763AC, https://asof.is/claim/clm_7124FBE763AC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_7124FBE763AC","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"4,567,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7124FBE763AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-05"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 35,794,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_7FAB128C3F5D, https://asof.is/claim/clm_7FAB128C3F5D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_7FAB128C3F5D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"35,794,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7FAB128C3F5D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2021, filed 2021-11-05"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 93,494,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_8FBD1A9DB37D, https://asof.is/claim/clm_8FBD1A9DB37D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_8FBD1A9DB37D","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"93,494,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8FBD1A9DB37D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-11-05"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 13,154,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_B112868B77BC, https://asof.is/claim/clm_B112868B77BC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_B112868B77BC","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"13,154,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B112868B77BC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2021, filed 2021-11-05"}},{"date":"2021-10-31","until":"2022-01-31","published":"2021-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,525,943,936 shares\", as of 2021-10-31 (until 2022-01-31). Claim clm_034CAAEA4834, https://asof.is/claim/clm_034CAAEA4834, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015821000032/0000310158-21-000032-index.htm.","url":"https://asof.is/claim/clm_034CAAEA4834","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,525,943,936 shares","status":"superseded","assertable":true,"id":"clm_034CAAEA4834","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-11-05"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,694,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_0ED12C79C31B, https://asof.is/claim/clm_0ED12C79C31B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_0ED12C79C31B","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"105,694,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0ED12C79C31B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2022-02-25"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 38,184,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_0FA531F72A09, https://asof.is/claim/clm_0FA531F72A09, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_0FA531F72A09","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"38,184,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0FA531F72A09","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2021, filed 2022-02-25"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 48,704,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_1B82FCD1E106, https://asof.is/claim/clm_1B82FCD1E106, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_1B82FCD1E106","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"48,704,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B82FCD1E106","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2021, filed 2022-02-25"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,096,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_230B3C47EC80, https://asof.is/claim/clm_230B3C47EC80, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_230B3C47EC80","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,096,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_230B3C47EC80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2022-02-25"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 12,245,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_52D1E12C9A04, https://asof.is/claim/clm_52D1E12C9A04, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_52D1E12C9A04","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"12,245,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_52D1E12C9A04","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2021, filed 2022-02-25"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 13,049,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_D12FFF001055, https://asof.is/claim/clm_D12FFF001055, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_D12FFF001055","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"13,049,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D12FFF001055","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2022-02-25"}},{"date":"2022-01-31","until":"2022-04-30","published":"2022-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,527,733,606 shares\", as of 2022-01-31 (until 2022-04-30). Claim clm_A990AD910616, https://asof.is/claim/clm_A990AD910616, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/0000310158-22-000003-index.htm.","url":"https://asof.is/claim/clm_A990AD910616","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,527,733,606 shares","status":"superseded","assertable":true,"id":"clm_A990AD910616","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2021, filed 2022-02-25"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,576,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_0B9FE3DC3835, https://asof.is/claim/clm_0B9FE3DC3835, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_0B9FE3DC3835","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,576,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0B9FE3DC3835","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2022, filed 2022-05-05"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 40,883,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_1B94B2C3A373, https://asof.is/claim/clm_1B94B2C3A373, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_1B94B2C3A373","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"40,883,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B94B2C3A373","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2022-05-05"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,668,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_4630F75144F2, https://asof.is/claim/clm_4630F75144F2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_4630F75144F2","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,668,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4630F75144F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2022-05-05"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,901,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_7ADB25B68A37, https://asof.is/claim/clm_7ADB25B68A37, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_7ADB25B68A37","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"15,901,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7ADB25B68A37","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2022, filed 2022-05-05"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,556,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_F618911BB8FA, https://asof.is/claim/clm_F618911BB8FA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_F618911BB8FA","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,556,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F618911BB8FA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-05-05"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,310,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_F9B19A8CB34A, https://asof.is/claim/clm_F9B19A8CB34A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_F9B19A8CB34A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"4,310,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F9B19A8CB34A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2022-05-05"}},{"date":"2022-04-30","until":"2022-07-31","published":"2022-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,528,805,025 shares\", as of 2022-04-30 (until 2022-07-31). Claim clm_005E05AF6D5A, https://asof.is/claim/clm_005E05AF6D5A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000011/0000310158-22-000011-index.htm.","url":"https://asof.is/claim/clm_005E05AF6D5A","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,528,805,025 shares","status":"superseded","assertable":true,"id":"clm_005E05AF6D5A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2022, filed 2022-05-05"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,243,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_1E7926206718, https://asof.is/claim/clm_1E7926206718, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_1E7926206718","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"43,243,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E7926206718","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2022, filed 2022-08-05"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 2,798,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_604E84C45015, https://asof.is/claim/clm_604E84C45015, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_604E84C45015","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"2,798,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_604E84C45015","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2022, filed 2022-08-05"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,675,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_7A280FC574C3, https://asof.is/claim/clm_7A280FC574C3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_7A280FC574C3","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"9,675,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A280FC574C3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2022-08-05"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,944,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_83A31C592A58, https://asof.is/claim/clm_83A31C592A58, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_83A31C592A58","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"3,944,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_83A31C592A58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2022-08-05"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 107,095,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_B3973D6129B8, https://asof.is/claim/clm_B3973D6129B8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_B3973D6129B8","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"107,095,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B3973D6129B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2022-08-05"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 14,593,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_C37B63E56958, https://asof.is/claim/clm_C37B63E56958, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_C37B63E56958","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"14,593,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C37B63E56958","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2022, filed 2022-08-05"}},{"date":"2022-07-31","until":"2022-10-31","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,533,279,845 shares\", as of 2022-07-31 (until 2022-10-31). Claim clm_5509A8889DE0, https://asof.is/claim/clm_5509A8889DE0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000030/0000310158-22-000030-index.htm.","url":"https://asof.is/claim/clm_5509A8889DE0","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,533,279,845 shares","status":"superseded","assertable":true,"id":"clm_5509A8889DE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2022, filed 2022-08-05"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 14,959,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_0A8F928CFC04, https://asof.is/claim/clm_0A8F928CFC04, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_0A8F928CFC04","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"14,959,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A8F928CFC04","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2022, filed 2022-11-03"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,248,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_1C94927C303E, https://asof.is/claim/clm_1C94927C303E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_1C94927C303E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"3,248,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1C94927C303E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-03"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,399,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_2E6751788C0B, https://asof.is/claim/clm_2E6751788C0B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_2E6751788C0B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"4,399,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2E6751788C0B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2022, filed 2022-11-03"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 107,081,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_39CF5C3FBCD8, https://asof.is/claim/clm_39CF5C3FBCD8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_39CF5C3FBCD8","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"107,081,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39CF5C3FBCD8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-11-03"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,458,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_6012CA07BC66, https://asof.is/claim/clm_6012CA07BC66, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_6012CA07BC66","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"44,458,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6012CA07BC66","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-11-03"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,145,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_96DAE1AA412B, https://asof.is/claim/clm_96DAE1AA412B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_96DAE1AA412B","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"11,145,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_96DAE1AA412B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-11-03"}},{"date":"2022-10-31","until":"2023-01-31","published":"2022-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,535,395,974 shares\", as of 2022-10-31 (until 2023-01-31). Claim clm_ACD78053B586, https://asof.is/claim/clm_ACD78053B586, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015822000034/0000310158-22-000034-index.htm.","url":"https://asof.is/claim/clm_ACD78053B586","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,535,395,974 shares","status":"superseded","assertable":true,"id":"clm_ACD78053B586","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2022, filed 2022-11-03"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 13,548,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_072FE6304876, https://asof.is/claim/clm_072FE6304876, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_072FE6304876","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"13,548,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_072FE6304876","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2022, filed 2023-02-24"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 12,694,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_3F973E2A6316, https://asof.is/claim/clm_3F973E2A6316, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_3F973E2A6316","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"12,694,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3F973E2A6316","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2023-02-24"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 109,160,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_5F726FFCF0E7, https://asof.is/claim/clm_5F726FFCF0E7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_5F726FFCF0E7","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"109,160,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5F726FFCF0E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2023-02-24"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 14,519,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_6570159626A7, https://asof.is/claim/clm_6570159626A7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_6570159626A7","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"14,519,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6570159626A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2023-02-24"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 59,283,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_B88AE5A69CF1, https://asof.is/claim/clm_B88AE5A69CF1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_B88AE5A69CF1","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"59,283,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B88AE5A69CF1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2022, filed 2023-02-24"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 45,991,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_D324B5015E5C, https://asof.is/claim/clm_D324B5015E5C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_D324B5015E5C","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"45,991,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D324B5015E5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2022, filed 2023-02-24"}},{"date":"2023-01-31","until":"2023-04-30","published":"2023-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,538,592,467 shares\", as of 2023-01-31 (until 2023-04-30). Claim clm_0DECBB030961, https://asof.is/claim/clm_0DECBB030961, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/0001628280-23-005061-index.htm.","url":"https://asof.is/claim/clm_0DECBB030961","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,538,592,467 shares","status":"superseded","assertable":true,"id":"clm_0DECBB030961","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2022, filed 2023-02-24"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 46,834,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_09E404D0868B, https://asof.is/claim/clm_09E404D0868B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_09E404D0868B","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"46,834,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_09E404D0868B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-05-05"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 14,487,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_353C9EC1DE74, https://asof.is/claim/clm_353C9EC1DE74, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_353C9EC1DE74","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"14,487,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_353C9EC1DE74","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2023, filed 2023-05-05"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 107,796,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_89BCC3ECADC9, https://asof.is/claim/clm_89BCC3ECADC9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_89BCC3ECADC9","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"107,796,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_89BCC3ECADC9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2023-05-05"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,707,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_C41F804AD4A0, https://asof.is/claim/clm_C41F804AD4A0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_C41F804AD4A0","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"9,707,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C41F804AD4A0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-05-05"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 2,821,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_E5378AE4C74A, https://asof.is/claim/clm_E5378AE4C74A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_E5378AE4C74A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"2,821,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E5378AE4C74A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-05"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,276,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_FD249791F8E3, https://asof.is/claim/clm_FD249791F8E3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_FD249791F8E3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"4,276,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FD249791F8E3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2023, filed 2023-05-05"}},{"date":"2023-04-30","until":"2023-07-31","published":"2023-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,537,435,954 shares\", as of 2023-04-30 (until 2023-07-31). Claim clm_F79642CF67D5, https://asof.is/claim/clm_F79642CF67D5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023015990/0001628280-23-015990-index.htm.","url":"https://asof.is/claim/clm_F79642CF67D5","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,537,435,954 shares","status":"superseded","assertable":true,"id":"clm_F79642CF67D5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2023, filed 2023-05-05"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 104,469,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_1A32EEA6D6EC, https://asof.is/claim/clm_1A32EEA6D6EC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_1A32EEA6D6EC","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"104,469,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A32EEA6D6EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2023-08-07"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 38,693,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_24E9A9145867, https://asof.is/claim/clm_24E9A9145867, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_24E9A9145867","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"38,693,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_24E9A9145867","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2023, filed 2023-08-07"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 13,321,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_2AC71CAE212F, https://asof.is/claim/clm_2AC71CAE212F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_2AC71CAE212F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"13,321,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2AC71CAE212F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2023, filed 2023-08-07"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,660,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_491D9D1C284F, https://asof.is/claim/clm_491D9D1C284F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_491D9D1C284F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"5,660,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_491D9D1C284F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2023-08-07"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: -5,975,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_808DE613CD03, https://asof.is/claim/clm_808DE613CD03, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_808DE613CD03","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"-5,975,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_808DE613CD03","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-07"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,035,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_CD754CF29134, https://asof.is/claim/clm_CD754CF29134, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_CD754CF29134","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"15,035,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CD754CF29134","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2023, filed 2023-08-07"}},{"date":"2023-07-31","until":"2023-10-31","published":"2023-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,537,521,169 shares\", as of 2023-07-31 (until 2023-10-31). Claim clm_694106887509, https://asof.is/claim/clm_694106887509, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023027770/0001628280-23-027770-index.htm.","url":"https://asof.is/claim/clm_694106887509","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,537,521,169 shares","status":"superseded","assertable":true,"id":"clm_694106887509","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2023-08-07"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,962,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_65DECC611D27, https://asof.is/claim/clm_65DECC611D27, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_65DECC611D27","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"15,962,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65DECC611D27","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,307,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_85D17F8D14B8, https://asof.is/claim/clm_85D17F8D14B8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_85D17F8D14B8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"3,307,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_85D17F8D14B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,605,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_C7767A31CAA9, https://asof.is/claim/clm_C7767A31CAA9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_C7767A31CAA9","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,605,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C7767A31CAA9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,745,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_DBF24049DC48, https://asof.is/claim/clm_DBF24049DC48, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_DBF24049DC48","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"4,745,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DBF24049DC48","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 41,246,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_EC64212C5C0B, https://asof.is/claim/clm_EC64212C5C0B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_EC64212C5C0B","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"41,246,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EC64212C5C0B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,727,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_ED1497B9B9A8, https://asof.is/claim/clm_ED1497B9B9A8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_ED1497B9B9A8","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,727,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ED1497B9B9A8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-10-31","until":"2024-01-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,534,023,084 shares\", as of 2023-10-31 (until 2024-01-31). Claim clm_88B7C84F347E, https://asof.is/claim/clm_88B7C84F347E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828023036717/0001628280-23-036717-index.htm.","url":"https://asof.is/claim/clm_88B7C84F347E","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,534,023,084 shares","status":"superseded","assertable":true,"id":"clm_88B7C84F347E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 365,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_00E79EEE61A1, https://asof.is/claim/clm_00E79EEE61A1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_00E79EEE61A1","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"365,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_00E79EEE61A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2024-02-26"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 106,675,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_26E68DAA6E4F, https://asof.is/claim/clm_26E68DAA6E4F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_26E68DAA6E4F","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,675,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_26E68DAA6E4F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2024-02-26"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,841,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_8B721020A859, https://asof.is/claim/clm_8B721020A859, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_8B721020A859","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,841,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B721020A859","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2024-02-26"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 30,531,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_9F3A2514948A, https://asof.is/claim/clm_9F3A2514948A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_9F3A2514948A","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"30,531,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F3A2514948A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2023, filed 2024-02-26"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 60,115,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_ABA0DDBCEC64, https://asof.is/claim/clm_ABA0DDBCEC64, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_ABA0DDBCEC64","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"60,115,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ABA0DDBCEC64","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2023, filed 2024-02-26"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 37,581,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_D509213C3811, https://asof.is/claim/clm_D509213C3811, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_D509213C3811","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"37,581,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D509213C3811","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2023, filed 2024-02-26"}},{"date":"2024-01-29","until":null,"published":"2024-02-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. restructuring: 2024 Restructuring Program optimizing Human Health and Animal Health manufacturing networks through 2031.\", as of 2024-01-29. Claim clm_96AE0D1A1AAA, https://asof.is/claim/clm_96AE0D1A1AAA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000110465924009109/0001104659-24-009109-index.htm.","url":"https://asof.is/claim/clm_96AE0D1A1AAA","accessed":"2026-11-10"},"kind":"money","predicate":"restructuring","value":"2024 Restructuring Program optimizing Human Health and Animal Health manufacturing networks through 2031.","status":"valid","assertable":true,"id":"clm_96AE0D1A1AAA","evidence":{"by":"page-read","on":"2026-11-09","quote":"On January 29, 2024, the Company approved a new restructuring program (the “2024 Restructuring Program”) intended to continue the optimization of the Company’s Human Health global manufacturing network as the future pipeline shifts to new modalities and also optimize the Animal Health global","url":"https://www.sec.gov/Archives/edgar/data/310158/000110465924009109/0001104659-24-009109-index.htm"}},{"date":"2024-01-31","until":"2024-04-30","published":"2024-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,532,643,872 shares\", as of 2024-01-31 (until 2024-04-30). Claim clm_95A1CC25AF02, https://asof.is/claim/clm_95A1CC25AF02, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/0001628280-24-006850-index.htm.","url":"https://asof.is/claim/clm_95A1CC25AF02","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,532,643,872 shares","status":"superseded","assertable":true,"id":"clm_95A1CC25AF02","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2023, filed 2024-02-26"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,762,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_19ED07FEF676, https://asof.is/claim/clm_19ED07FEF676, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_19ED07FEF676","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"4,762,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_19ED07FEF676","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-03"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,579,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_61D652C2AA20, https://asof.is/claim/clm_61D652C2AA20, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_61D652C2AA20","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"5,579,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_61D652C2AA20","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2024-05-03"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,775,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_8611BE831E10, https://asof.is/claim/clm_8611BE831E10, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_8611BE831E10","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"15,775,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8611BE831E10","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2024, filed 2024-05-03"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 40,364,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_866522253978, https://asof.is/claim/clm_866522253978, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_866522253978","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"40,364,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_866522253978","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2024, filed 2024-05-03"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 105,849,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_BDB2E27B4E60, https://asof.is/claim/clm_BDB2E27B4E60, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_BDB2E27B4E60","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"105,849,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BDB2E27B4E60","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2024-05-03"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,992,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_DD2E2358C2C5, https://asof.is/claim/clm_DD2E2358C2C5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_DD2E2358C2C5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"3,992,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD2E2358C2C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2024, filed 2024-05-03"}},{"date":"2024-04-30","until":"2024-07-31","published":"2024-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,532,806,307 shares\", as of 2024-04-30 (until 2024-07-31). Claim clm_84C234FF7850, https://asof.is/claim/clm_84C234FF7850, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024020283/0001628280-24-020283-index.htm.","url":"https://asof.is/claim/clm_84C234FF7850","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,532,806,307 shares","status":"superseded","assertable":true,"id":"clm_84C234FF7850","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2024, filed 2024-05-03"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 112,630,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_0F3839AEFD94, https://asof.is/claim/clm_0F3839AEFD94, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_0F3839AEFD94","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"112,630,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0F3839AEFD94","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2024-08-05"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 43,582,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_34EB6E01BD4E, https://asof.is/claim/clm_34EB6E01BD4E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_34EB6E01BD4E","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"43,582,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_34EB6E01BD4E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2024, filed 2024-08-05"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 11,304,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_53A19AADAE82, https://asof.is/claim/clm_53A19AADAE82, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_53A19AADAE82","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"11,304,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_53A19AADAE82","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2024-08-05"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,500,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_64E8125CC2B5, https://asof.is/claim/clm_64E8125CC2B5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_64E8125CC2B5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"3,500,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_64E8125CC2B5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2024, filed 2024-08-05"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,455,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_9D2EE4822EFB, https://asof.is/claim/clm_9D2EE4822EFB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_9D2EE4822EFB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"5,455,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D2EE4822EFB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2024-08-05"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 16,112,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_CA3727C7A4E6, https://asof.is/claim/clm_CA3727C7A4E6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_CA3727C7A4E6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"16,112,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CA3727C7A4E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2024, filed 2024-08-05"}},{"date":"2024-07-31","until":"2024-10-31","published":"2024-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,534,809,312 shares\", as of 2024-07-31 (until 2024-10-31). Claim clm_CA8B975E05B4, https://asof.is/claim/clm_CA8B975E05B4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.","url":"https://asof.is/claim/clm_CA8B975E05B4","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,534,809,312 shares","status":"superseded","assertable":true,"id":"clm_CA8B975E05B4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2024, filed 2024-08-05"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,593,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_32776455365F, https://asof.is/claim/clm_32776455365F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_32776455365F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"14,593,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_32776455365F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,502,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_452ECF596A5A, https://asof.is/claim/clm_452ECF596A5A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_452ECF596A5A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"44,502,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_452ECF596A5A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 3,157,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_7D92F6A5B925, https://asof.is/claim/clm_7D92F6A5B925, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_7D92F6A5B925","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"3,157,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7D92F6A5B925","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 16,657,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_81BBE85997B1, https://asof.is/claim/clm_81BBE85997B1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_81BBE85997B1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"16,657,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_81BBE85997B1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 117,532,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_A6EF3EF9F17B, https://asof.is/claim/clm_A6EF3EF9F17B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_A6EF3EF9F17B","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"117,532,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A6EF3EF9F17B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 5,862,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_EF9F40E4249B, https://asof.is/claim/clm_EF9F40E4249B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_EF9F40E4249B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"5,862,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EF9F40E4249B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-10-31","until":"2025-01-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,529,635,645 shares\", as of 2024-10-31 (until 2025-01-31). Claim clm_EF29FF74A1DA, https://asof.is/claim/clm_EF29FF74A1DA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024045689/0001628280-24-045689-index.htm.","url":"https://asof.is/claim/clm_EF29FF74A1DA","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,529,635,645 shares","status":"superseded","assertable":true,"id":"clm_EF29FF74A1DA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 117,106,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_10EEDDF5060A, https://asof.is/claim/clm_10EEDDF5060A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_10EEDDF5060A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"117,106,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_10EEDDF5060A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2025-02-25"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 46,313,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_5998C6109ED8, https://asof.is/claim/clm_5998C6109ED8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_5998C6109ED8","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"46,313,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5998C6109ED8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2024, filed 2025-02-25"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 13,242,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_836E3FCB29EF, https://asof.is/claim/clm_836E3FCB29EF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_836E3FCB29EF","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"13,242,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_836E3FCB29EF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2025-02-25"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 64,168,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_B00A59ED1285, https://asof.is/claim/clm_B00A59ED1285, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_B00A59ED1285","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"64,168,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B00A59ED1285","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-25"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 17,938,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_B017880F2FAE, https://asof.is/claim/clm_B017880F2FAE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_B017880F2FAE","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"17,938,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B017880F2FAE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-25"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 17,117,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_C6B723CD22D3, https://asof.is/claim/clm_C6B723CD22D3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_C6B723CD22D3","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"17,117,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C6B723CD22D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-25"}},{"date":"2025-01-31","until":"2025-04-30","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,526,036,240 shares\", as of 2025-01-31 (until 2025-04-30). Claim clm_F14BC63CE196, https://asof.is/claim/clm_F14BC63CE196, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/0001628280-25-007732-index.htm.","url":"https://asof.is/claim/clm_F14BC63CE196","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,526,036,240 shares","status":"superseded","assertable":true,"id":"clm_F14BC63CE196","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2024, filed 2025-02-25"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 48,335,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_2B02E20CD535, https://asof.is/claim/clm_2B02E20CD535, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_2B02E20CD535","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"48,335,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2B02E20CD535","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,629,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_6E7A454B6848, https://asof.is/claim/clm_6E7A454B6848, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_6E7A454B6848","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,629,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E7A454B6848","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 3,621,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_788ACEC11B0D, https://asof.is/claim/clm_788ACEC11B0D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_788ACEC11B0D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"3,621,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_788ACEC11B0D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,529,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_9639B624984C, https://asof.is/claim/clm_9639B624984C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_9639B624984C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"15,529,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9639B624984C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 115,122,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_A6351EF8D62A, https://asof.is/claim/clm_A6351EF8D62A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_A6351EF8D62A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"115,122,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A6351EF8D62A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,079,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_D254D3EB3376, https://asof.is/claim/clm_D254D3EB3376, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_D254D3EB3376","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"5,079,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D254D3EB3376","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-04-30","until":"2025-07-31","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,511,031,253 shares\", as of 2025-04-30 (until 2025-07-31). Claim clm_37C45B0F3389, https://asof.is/claim/clm_37C45B0F3389, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828025021834/0001628280-25-021834-index.htm.","url":"https://asof.is/claim/clm_37C45B0F3389","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,511,031,253 shares","status":"superseded","assertable":true,"id":"clm_37C45B0F3389","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,048,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_6E0F8CB5C8F7, https://asof.is/claim/clm_6E0F8CB5C8F7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_6E0F8CB5C8F7","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"4,048,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E0F8CB5C8F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2025, filed 2025-08-05"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 8,007,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_9989FAB3CB44, https://asof.is/claim/clm_9989FAB3CB44, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_9989FAB3CB44","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"8,007,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9989FAB3CB44","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2025-08-05"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 15,806,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_A023A3BF80C0, https://asof.is/claim/clm_A023A3BF80C0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_A023A3BF80C0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"15,806,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A023A3BF80C0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2025, filed 2025-08-05"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 4,427,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_CB2E2563DBAE, https://asof.is/claim/clm_CB2E2563DBAE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_CB2E2563DBAE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"4,427,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CB2E2563DBAE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2025, filed 2025-08-05"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 48,993,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_CD7198CC2749, https://asof.is/claim/clm_CD7198CC2749, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_CD7198CC2749","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"48,993,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CD7198CC2749","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2025, filed 2025-08-05"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 117,523,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_FF7386E5859A, https://asof.is/claim/clm_FF7386E5859A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_FF7386E5859A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"117,523,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FF7386E5859A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2025-08-05"}},{"date":"2025-07-25","until":null,"published":"2025-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. restructuring: 2025 Restructuring Program cutting positions, real estate and manufacturing footprint\", as of 2025-07-25. Claim clm_F555D4E17854, https://asof.is/claim/clm_F555D4E17854, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000110465925071380/0001104659-25-071380-index.htm.","url":"https://asof.is/claim/clm_F555D4E17854","accessed":"2026-11-10"},"kind":"money","predicate":"restructuring","value":"2025 Restructuring Program cutting positions, real estate and manufacturing footprint","status":"valid","assertable":true,"id":"clm_F555D4E17854","evidence":{"by":"page-read","on":"2026-11-09","quote":"On July 25, 2025, the Company approved a new restructuring program (2025 Restructuring Program) designed to position the Company for its next chapter of growth and to successfully advance its pipeline and launch new products across multiple therapeutic areas.","url":"https://www.sec.gov/Archives/edgar/data/310158/000110465925071380/0001104659-25-071380-index.htm"}},{"date":"2025-07-31","until":"2025-10-31","published":"2025-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,497,783,211 shares\", as of 2025-07-31 (until 2025-10-31). Claim clm_DF652357EB7C, https://asof.is/claim/clm_DF652357EB7C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000014/0000310158-25-000014-index.htm.","url":"https://asof.is/claim/clm_DF652357EB7C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,497,783,211 shares","status":"superseded","assertable":true,"id":"clm_DF652357EB7C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2025, filed 2025-08-05"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,785,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_44C6DC623BB5, https://asof.is/claim/clm_44C6DC623BB5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_44C6DC623BB5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"5,785,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_44C6DC623BB5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-11-05"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 129,546,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_7F62C5E7C6D5, https://asof.is/claim/clm_7F62C5E7C6D5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_7F62C5E7C6D5","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"129,546,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7F62C5E7C6D5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-11-05"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 17,276,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_86C0BCF4E479, https://asof.is/claim/clm_86C0BCF4E479, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_86C0BCF4E479","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"17,276,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_86C0BCF4E479","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-11-05"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 51,850,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_BDAEC6471AF2, https://asof.is/claim/clm_BDAEC6471AF2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_BDAEC6471AF2","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,850,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BDAEC6471AF2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-11-05"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 18,169,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_C86D1A2441BE, https://asof.is/claim/clm_C86D1A2441BE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_C86D1A2441BE","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"18,169,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C86D1A2441BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-11-05"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,234,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_E7C205B81C1E, https://asof.is/claim/clm_E7C205B81C1E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_E7C205B81C1E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"4,234,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E7C205B81C1E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2025, filed 2025-11-05"}},{"date":"2025-10-31","until":"2026-01-31","published":"2025-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,482,022,536 shares\", as of 2025-10-31 (until 2026-01-31). Claim clm_216265EA32A0, https://asof.is/claim/clm_216265EA32A0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.","url":"https://asof.is/claim/clm_216265EA32A0","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,482,022,536 shares","status":"superseded","assertable":true,"id":"clm_216265EA32A0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-11-05"}},{"date":"2025-12-31","until":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. research and development: 15,789,000,000 United States dollar\", as of 2025-12-31. Claim clm_062934F11209, https://asof.is/claim/clm_062934F11209, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_062934F11209","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"15,789,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_062934F11209","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-24"}},{"date":"2025-12-31","until":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. net income: 18,254,000,000 United States dollar\", as of 2025-12-31. Claim clm_23107EF0C145, https://asof.is/claim/clm_23107EF0C145, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_23107EF0C145","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"18,254,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_23107EF0C145","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-24"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 52,606,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_4011DB45C7C0, https://asof.is/claim/clm_4011DB45C7C0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_4011DB45C7C0","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"52,606,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4011DB45C7C0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2025, filed 2026-02-24"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 136,866,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_4A91E3E067AC, https://asof.is/claim/clm_4A91E3E067AC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_4A91E3E067AC","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"136,866,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4A91E3E067AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2026-02-24"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 14,565,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_DB573F068746, https://asof.is/claim/clm_DB573F068746, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_DB573F068746","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"14,565,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DB573F068746","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2026-02-24"}},{"date":"2025-12-31","until":null,"published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. revenue: 65,011,000,000 United States dollar\", as of 2025-12-31. Claim clm_E778C75FD821, https://asof.is/claim/clm_E778C75FD821, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_E778C75FD821","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"65,011,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_E778C75FD821","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-24"}},{"date":"2026-01-31","until":"2026-04-30","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,472,392,003 shares\", as of 2026-01-31 (until 2026-04-30). Claim clm_816D1195758B, https://asof.is/claim/clm_816D1195758B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/0000310158-26-000063-index.htm.","url":"https://asof.is/claim/clm_816D1195758B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,472,392,003 shares","status":"superseded","assertable":true,"id":"clm_816D1195758B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2025, filed 2026-02-24"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: -4,240,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_052408C1DABC, https://asof.is/claim/clm_052408C1DABC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_052408C1DABC","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"-4,240,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_052408C1DABC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2026-05-04"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 45,878,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_2EAD708A2D4D, https://asof.is/claim/clm_2EAD708A2D4D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_2EAD708A2D4D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"45,878,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2EAD708A2D4D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2026, filed 2026-05-04"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 5,327,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_4EF7F384C3E5, https://asof.is/claim/clm_4EF7F384C3E5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_4EF7F384C3E5","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"5,327,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4EF7F384C3E5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2026-05-04"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 128,685,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_6DF831C7A399, https://asof.is/claim/clm_6DF831C7A399, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_6DF831C7A399","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"128,685,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6DF831C7A399","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2026-05-04"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 16,286,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_A5059DD1C3C6, https://asof.is/claim/clm_A5059DD1C3C6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_A5059DD1C3C6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"16,286,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A5059DD1C3C6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2026, filed 2026-05-04"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 12,592,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_CC42DDED77FE, https://asof.is/claim/clm_CC42DDED77FE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_CC42DDED77FE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"12,592,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CC42DDED77FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2026, filed 2026-05-04"}},{"date":"2026-04-30","until":"2026-07-31","published":"2026-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,469,824,415 shares\", as of 2026-04-30 (until 2026-07-31). Claim clm_3D54FBDF161B, https://asof.is/claim/clm_3D54FBDF161B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828026029802/0001628280-26-029802-index.htm.","url":"https://asof.is/claim/clm_3D54FBDF161B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,469,824,415 shares","status":"superseded","assertable":true,"id":"clm_3D54FBDF161B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2026, filed 2026-05-04"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 129,802,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_1D21FB857339, https://asof.is/claim/clm_1D21FB857339, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_1D21FB857339","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"129,802,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1D21FB857339","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2026-08-07"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: -1,335,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_3CFDEE3E892F, https://asof.is/claim/clm_3CFDEE3E892F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_3CFDEE3E892F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"-1,335,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3CFDEE3E892F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-08-07"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 41,933,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_56023EED76B1, https://asof.is/claim/clm_56023EED76B1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_56023EED76B1","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"41,933,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56023EED76B1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2026-08-07"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 16,607,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_59257F264468, https://asof.is/claim/clm_59257F264468, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_59257F264468","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"16,607,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59257F264468","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2026, filed 2026-08-07"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 9,741,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_6963A9FE29D9, https://asof.is/claim/clm_6963A9FE29D9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_6963A9FE29D9","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"9,741,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6963A9FE29D9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2026, filed 2026-08-07"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 6,849,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_9B76B2EBE76B, https://asof.is/claim/clm_9B76B2EBE76B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_9B76B2EBE76B","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,849,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9B76B2EBE76B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2026-08-07"}},{"date":"2026-07-31","until":"2026-10-31","published":"2026-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,467,171,638 shares\", as of 2026-07-31 (until 2026-10-31). Claim clm_551368D9DFD9, https://asof.is/claim/clm_551368D9DFD9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.","url":"https://asof.is/claim/clm_551368D9DFD9","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,467,171,638 shares","status":"superseded","assertable":true,"id":"clm_551368D9DFD9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2026, filed 2026-08-07"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total equity: 44,893,000,000 United States dollar\", as of 2026-09-30. Claim clm_23DBC8C334E1, https://asof.is/claim/clm_23DBC8C334E1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_23DBC8C334E1","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"44,893,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_23DBC8C334E1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. cash and equivalents: 9,550,000,000 United States dollar\", as of 2026-09-30. Claim clm_5760FE8DF5CC, https://asof.is/claim/clm_5760FE8DF5CC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_5760FE8DF5CC","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"9,550,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_5760FE8DF5CC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. total assets: 132,773,000,000 United States dollar\", as of 2026-09-30. Claim clm_700C48638C17, https://asof.is/claim/clm_700C48638C17, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_700C48638C17","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"132,773,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_700C48638C17","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly research and development: 4,537,000,000 United States dollar\", as of 2026-09-30. Claim clm_8D15B1B2A78D, https://asof.is/claim/clm_8D15B1B2A78D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_8D15B1B2A78D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"4,537,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_8D15B1B2A78D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly net income: 5,065,000,000 United States dollar\", as of 2026-09-30. Claim clm_BE2114005849, https://asof.is/claim/clm_BE2114005849, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_BE2114005849","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"5,065,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_BE2114005849","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. quarterly revenue: 18,085,000,000 United States dollar\", as of 2026-09-30. Claim clm_D93F566AE261, https://asof.is/claim/clm_D93F566AE261, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_D93F566AE261","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"18,085,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_D93F566AE261","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-10-31","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Merck & Co. shares outstanding: 2,465,245,688 shares\", as of 2026-10-31. Claim clm_B0FE93A73A8D, https://asof.is/claim/clm_B0FE93A73A8D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000248/0000310158-26-000248-index.htm.","url":"https://asof.is/claim/clm_B0FE93A73A8D","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"2,465,245,688 shares","status":"valid","assertable":true,"id":"clm_B0FE93A73A8D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-11-04"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing","page-read":"its source page states the value and the date"}}}